Category: GlobeNewswire

  • MIL-OSI: KANZHUN LIMITED Releases 2024 Environmental, Social and Governance Report

    Source: GlobeNewswire (MIL-OSI)

    BEIJING, April 10, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today published its 2024 Environmental, Social and Governance (“ESG”) report (“the report”), reaffirming the Company’s unwavering commitment to fostering a responsible and sustainable online recruitment platform that empowers job seekers, supports business development, and generates long-term societal value.

    The report outlines the Company’s achievements and impacts across seven key ESG dimensions: ESG governance, products and services optimization, employee growth, green development, sustainable supply chain practices, community engagement, and standardized corporate governance, cultivating an ecosystem where opportunity, equity, and innovation thrive. By embedding sustainability into its core operations, the Company is dedicated to delivering lasting value to users, stakeholders, and society as a whole.

    To access the full report, please visit the Sustainability section of the Company’s investor relations website at https://ir.zhipin.com.

    About KANZHUN LIMITED

    KANZHUN LIMITED operates the leading online recruitment platform BOSS Zhipin in China. The Company connects job seekers and enterprise users in an efficient and seamless manner through its highly interactive mobile app, a transformative product that promotes two-way communication, focuses on intelligent recommendations, and creates new scenarios in the online recruiting process. Benefiting from its large and diverse user base, BOSS Zhipin has developed powerful network effects to deliver higher recruitment efficiency and drive rapid expansion.

    For investor and media inquiries, please contact:

    KANZHUN LIMITED
    Investor Relations
    Email: ir@kanzhun.com

    PIACENTE FINANCIAL COMMUNICATIONS
    Email: kanzhun@tpg-ir.com

    The MIL Network

  • MIL-OSI: KANZHUN LIMITED Files Its Annual Report on Form 20-F

    Source: GlobeNewswire (MIL-OSI)

    BEIJING, April 10, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 10, 2025, U.S. Eastern Time. The annual report can be accessed on the Company’s investor relations website at https://ir.zhipin.com.

    The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to the Investor Relations Department of KANZHUN LIMITED via email at ir@kanzhun.com.

    The Company has also published its annual report for Hong Kong purposes pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (“HKEX”), which can be accessed on the Company’s investor relations website at https://ir.zhipin.com as well as the HKEX’s website at http://www.hkexnews.hk.

    About KANZHUN LIMITED

    KANZHUN LIMITED operates the leading online recruitment platform BOSS Zhipin in China. The Company connects job seekers and enterprise users in an efficient and seamless manner through its highly interactive mobile app, a transformative product that promotes two-way communication, focuses on intelligent recommendations, and creates new scenarios in the online recruiting process. Benefiting from its large and diverse user base, BOSS Zhipin has developed powerful network effects to deliver higher recruitment efficiency and drive rapid expansion.

    For investor and media inquiries, please contact:

    KANZHUN LIMITED
    Investor Relations
    Email: ir@kanzhun.com

    PIACENTE FINANCIAL COMMUNICATIONS
    Email: kanzhun@tpg-ir.com

    The MIL Network

  • MIL-OSI: OSS to Present at the Planet MicroCap Showcase: VEGAS 2025 April 23, 2025 to April 24, 2025

    Source: GlobeNewswire (MIL-OSI)

    ESCONDIDO, Calif., April 10, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on April 23, 2025 at 3:30 PM PT.

    To access the live presentation, please use the following information:

    Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub
    Date: Wednesday, April 23, 2025
    Time: 3:30 – 4:00 PM PT
    Webcast: https://event.summitcast.com/view/YNz6mnmEsXyrdRxb78w2nX/guest_book?session_id=3oUaBZRsjbv3k9PyooFjFH

    If you would like to book 1×1 investor meetings with OSS, and to attend the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, please make sure you are registered here: REGISTER

    1×1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV

    The Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub website is available here: HOME PAGE

    If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: AGENDA

    About One Stop Systems
    One Stop Systems, Inc. (Nasdaq: OSS) is a leader in AI enabled solutions for the demanding ‘edge’. OSS designs and manufactures Enterprise Class compute and storage products that enable rugged AI, sensor fusion and autonomous capabilities without compromise. These hardware and software platforms bring the latest data center performance to harsh and challenging applications, whether they are on land, sea or in the air.

    OSS products include ruggedized servers, compute accelerators, flash storage arrays, and storage acceleration software. These specialized compact products are used across multiple industries and applications, including autonomous trucking and farming, as well as aircraft, drones, ships and vehicles within the defense industry.

    OSS solutions address the entire AI workflow, from high-speed data acquisition to deep learning, training and large-scale inference, and have delivered many industry firsts for industrial OEM and government customers.

    As the fastest growing segment of the multi-billion-dollar edge computing market, AI enabled solutions require-and OSS delivers-the highest level of performance in the most challenging environments without compromise.

    OSS products are available directly or through global distributors. For more information, go to www.onestopsystems.com. You can also follow OSS on X, YouTube, and LinkedIn.

    About Planet MicroCap
    Planet MicroCap is a global multimedia financial news, publishing and events company for the MicroCap investing community. Planet MicroCap has cultivated an active and engaged audience of folks that are interested in learning about and staying ahead of the curve in the MicroCap space.

    If you would like to attend the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, please register here: REGISTER

    Forward-Looking Statements
    OSS cautions you that statements in this press release that are not a description of historical facts are forward-looking statements. These statements are based on the Company’s current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation by OSS or its partners that any of our plans or expectations will be achieved, including but not limited to the potential and/or the results participating in the Planet MicroCap Conference, any results relating to one-on-one meetings with management, and the expansion of the Company’s offerings and/or relationship with commercial customers and/or investors. Actual results may differ from those set forth in this press release due to the risk and uncertainties inherent in our business, including risks described in our prior press releases and in our filings with the Securities and Exchange Commission (SEC), including under the heading “Risk Factors” in our latest Annual Report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the company undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

    Media Contacts:
    Robert Kalebaugh
    One Stop Systems, Inc.
    Tel (858) 518-6154
    Email contact

    Investor Relations:
    Andrew Berger
    Managing Director
    SM Berger & Company, Inc.
    Tel (216) 464-6400
    Email contact

    The MIL Network

  • MIL-OSI: c/side Launches Channel Partner Program as Zero-Day Web Dependency Attacks—and Compliance Pressure—Accelerate

    Source: GlobeNewswire (MIL-OSI)

    • Third-party web scripts are now the #1 source of web-based data breaches
    • Most companies do not even know which scripts are running on their site
    • PCI DSS 4.0.1 mandates new protections starting March 2025—non-compliance means fines, or worse

    SAN FRANCISCO, April 10, 2025 (GLOBE NEWSWIRE) — c/side, which specializes in securing vulnerable web dependencies, today launched its first-ever channel partner program. The new program enables managed service providers (MSPs), web development agencies, and security consultants with new revenue opportunities while protecting their clients from rising web dependency attacks and ensuring PCI DSS 4.0.1 compliance.

    Through a unified management dashboard, partners can offer c/side’s differentiated web security solutions to their clients with simplified onboarding and security monitoring. Early partners will receive priority access to technical support, co-marketing resources, and exclusive onboarding benefits through June 2025.

    Web dependencies loading in website visitors’ browsers (such as first- and third-party web scripts used for payment processing, analytics, and chatbots) are a major security risk to organizations large and small—as headlines continue to show. The most commonly deployed dependencies change weekly, often without a business knowing. When compromised, they can rewrite webpages, change crypto wallet IDs, redirect users to malicious sites, capture keystrokes, and more. Attack consequences range from significant financial damage to compliance issues to potential lawsuits.

    “Our channel partners are on the front lines helping clients across industries secure their websites and their customer data against increasingly sophisticated threats,” said Mike Kutlu, GTM Operations at c/side. “Our new program provides our partners with the tools, resources, and flexible business models they need to protect their clients from the quickly-evolving risks posed by compromised web scripts and other dependencies. With our unified dashboard approach, partners can manage all their client projects efficiently while offering a revenue-generating solution that makes their clients’ websites not just a lot more secure, but also run up to 30% faster.”

    With the PCI DSS 4.0.1 compliance deadline of March 31, 2025, organizations with websites that handle credit card data must implement tamper-detection mechanisms to mitigate increasingly sophisticated browser-side attacks. c/side’s partner program launches at an especially critical time, as businesses seek solutions that can detect unauthorized changes to HTTP headers, scripts, and other dependencies.

    Recent attacks continue to underscore the urgency: a staggering $1.5 billion was stolen in a malicious JavaScript attack on Bybit, while more than 150,000 websites were compromised by a malicious full-page hijack injection.

    c/side’s partners benefit from:

    • Uniquely thorough web security monitoring: Real-time, flow-through monitoring of third-party scripts across entire websites (not just payment portals) with no sampling and 100% coverage.
    • Seamless client management: A single dashboard to manage all client projects without the need for separate accounts or complex onboarding processes.
    • Flexible billing options: Partners can choose consolidated or split billing per customer, tailored to their preferred client relationship model.
    • PCI DSS 4.0.1 compliance support: Tools that help clients meet the strict requirements in sections 6.4.3 and 11.6.1 of the March 2025 enforcement mandate.
    • Advanced detection capabilities: Autonomous detection powered by AI that processes more than 1 million scripts daily and monitors more than 70 attributes to identify potential threats.

    Unlike other solutions that rely on sampling or basic threat feeds, c/side employs historical context and artificial intelligence to review both the payload and behavior of scripts, making it the most advanced detection system in the industry. The platform is compatible with popular e-commerce platforms and front-end technologies including Shopify, Magento, WooCommerce, and Next.js, as well as custom-built and traditional website architectures.

    “With c/side’s partner program, we’re empowering the channel to address a critical security gap that traditional security tools simply cannot handle,” said Simon Wijckmans, CEO and founder, c/side. “Our partners can now provide clients with protection against zero-day attacks while differentiating their services in an increasingly competitive market.”

    “c/side gave us the ability to monitor all of our clients’ websites with zero friction,” said Ben Alexander, Director of HomeMade Digital, a technology partner that helps modernize and secure websites. “The platform has been a game-changer for managing compliance and real-time risk.”

    MSPs, web development agencies, and security consultants, interested in joining c/side’s partner program can visit cside.dev/partners or contact the company at mike@cside.dev

    About c/side

    c/side is a venture-backed cybersecurity company specializing in browser-side threat detection and protection. The company’s platform provides complete visibility and control over vulnerable first- and third-party scripts running on websites, protecting sensitive visitor data while ensuring optimal website performance. c/side’s innovative technology enables customers to secure their web supply chain against sophisticated attacks and streamlines compliance with regulations such as PCI DSS 4.0.1.

    Contact
    Kyle Peterson
    kyle@clementpeterson.com

    The MIL Network

  • MIL-OSI: CERo Therapeutics Holdings, Inc. Announces Critical Patent Application Allowances from the U.S. Patent Office Covering Company’s Lead Compound CER-1236

    Source: GlobeNewswire (MIL-OSI)

    Results in 17 Issued and Allowed Patent Applications Internationally with Nine Total Patent Families

    SOUTH SAN FRANSCISCO, Calif, April 10, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces the allowance of two patent applications submitted to the U.S. Patent and Trademark Office (USPTO), which materially expands the Company’s intellectual property portfolio.

    Patent Application No. 17/040,472, titled, “CELLULAR IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF,” was allowed on March 13, 2025 and provides coverage for composition of matter and methods of use coverage for the Company’s lead compound,  CER-1236. The allowed claims encompass the combination of a phosphatidylserine-targeting CD4+ CER-T cell with a CD8+ CAR-T cell or a CD8+ recombinant TCR-T cell, and their use to treat cancer. This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed. 

    Additionally, the USPTO has issued a Notice of Allowance on March 24, 2025 for Patent Application No. 17/040,317, titled, “CHIMERIC TIM4 RECEPTORS AND USES THEREOF.” The allowed claims encompass some design aspects of CER-1236. This patent, once granted, provides composition of matter protection for a chimeric TIM4 receptor comprising a TIM4 binding domain and canonical T cell signaling domains. CERo’s intellectual property portfolio now includes 9 total patent families with protection out to 2039 in the United States.  With these additional allowed applications,  CER-1236 and its platform technology is supported by 17 total issued patents and allowed patent applications internationally.

    Chris Ehrlich, CERo Therapeutics CEO, commented, “These additional patent application allowances are paramount to CERo’s success in the market as they demonstrate the true novelty of our design and approach in potentially killing cancer cells and treating patients.  The robust range of patents that cover this technology in general, and CER-1236 in particular, are a continuation of the validation we have seen since the inception of the Company, demonstrating innovation — and we believe – therapeutic potential.  We are gratified to be receiving these allowances on the heels of the announcement of our initial trial site for our Phase 1 trial in AML and the announcement of our cleared IND to begin human trials to treat ovarian and non-small cell lung cancers.”

    About CERo Therapeutics Holdings, Inc.

    CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. This novel cellular immunotherapy platform is expected to redirect patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating what CERo refers to as Chimeric Engulfment Receptor T cells (“CER-T”). CERo believes the differentiated activity of CER-T cells will afford them greater therapeutic application than currently approved chimeric antigen receptor (“CAR-T”) cell therapy, as the use of CER-T may potentially span both hematological malignancies and solid tumors. CERo anticipates initiating clinical trials for its lead product candidate, CER-1236, in 2025 for hematological malignancies.

    Forward-Looking Statements

    This communication contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations of CERo and the implementation of its proposed plan of compliance with Nasdaq continued listing standards. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this communication, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When CERo discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, CERo’s management.

    Actual results could differ from those implied by the forward-looking statements in this communication. Certain risks that could cause actual results to differ are set forth in CERo’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, and the documents incorporated by reference therein. The risks described in CERo’s filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time, and it is not possible to predict all such risk factors, nor can CERo assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements made by CERo or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. CERo undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    Contact:
    Chris Ehrlich
    Chief Executive Officer
    chris@cero.bio

    Investors:
    CORE IR
    investors@cero.bio

    The MIL Network

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 09 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
    N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree
    ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure
    09 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”
    N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,862,906 5.4410    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,862,906 5.4410    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY SALE 3,240 184.6p
    5p ORDINARY SALE 21,590 198.4p
    5p ORDINARY PURCHASE 3,240 185.5453p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD
    Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position
    Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.
    Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option
    Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion
    Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 10 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network

  • MIL-OSI: Kaltura and Synthesia Announce Partnership to Deliver the Next Frontier in AI-Powered Video Creation and Distribution

    Source: GlobeNewswire (MIL-OSI)

    New York, April 10, 2025 (GLOBE NEWSWIRE) —

    Kaltura (Nasdaq: KLTR), the AI Video Experience Cloud, today announced a new partnership with Synthesia, a developer of hyper-realistic AI avatars for enterprises. This partnership will enable organizations using Kaltura’s video platform to distribute avatar-based, AI-generated video content at scale, measurably enhancing viewer engagement. With early testing already underway, Kaltura users are employing avatars in a wide variety of use cases across industries including healthcare, pharmaceuticals, technology, telecoms, higher education, and more.   

    As digital paradigms shift, traditional text-based learning struggles to captivate modern audiences, falling short in learning outcome and knowledge retention. By merging Synthesia’s pioneering AI avatars with Kaltura’s immersive AI video capabilities, organizations can now revolutionize learning with hyper-personalized, interactive content that captivates, inspires, and drives deeper knowledge retention. 

    Organizations already leveraging Kaltura’s video platform will be able to integrate AI-generated content and avatars into their workflows, unlocking new possibilities for: 

    • Enterprise Training & Onboarding: AI-generated training modules for employee training, compliance videos, and internal communications. 
    • Higher Education & E-Learning: Automated lecture content, multilingual courses, and AI-driven educational videos for universities and edtech companies.  
    • Marketing & Customer Engagement: AI-powered product demos, hyper-personalized marketing campaigns, and customer onboarding content. 
    • Healthcare & Financial Services: Automated regulatory training and client education videos tailored for compliance-driven industries. 

    Beyond enhancing engagement, the collaboration also reimagines video production, making it more accessible and cost-effective. AI-powered video creation eliminates the need for expensive studio shoots and extensive editing, allowing organizations to generate professional-quality content quickly and efficiently.  

    “At Kaltura, we are redefining the future of video by seamlessly merging personalization with immersive technology. Avatars represent the next evolution in hyper-personalization, transforming static content into dynamic, interactive experiences. Our collaboration with Synthesia is a bold step forward, setting new industry benchmarks for AI video innovation,” said Navi Azaria, Chief Product and Engineering Officer at Kaltura. 

    “Through our partnership with Kaltura, we will be able to bring our avatars to a broader audience and unlock new market opportunities,” said Brian Jambor, Head of Partnerships at Synthesia. “We’re looking forward to exploring new use cases, from enhancing enterprise training programs to tailoring education and employee onboarding.” 

    Learn more about Kaltura AI-infused video solutions, here.   

      

    About Kaltura 

    Kaltura’s mission is to create and power AI-infused hyper-personalized video experiences that boost customer and employee engagement and success. Kaltura’s AI Video Experience Cloud includes a platform for enterprise and TV content management and a wide array of Gen AI-infused video-first products, including Video Portals, LMS and CMS Video Extensions, Virtual Events and Webinars, Virtual Classrooms, and TV Streaming Applications. Kaltura engages millions of end-users at home, at work, and at school, boosting both customer and employee experiences, including marketing, sales, and customer success; teaching, learning, training and certification; communication and collaboration; and entertainment and monetization. For more information, visit  www.corp.kaltura.com 

    About Synthesia 

    Synthesia is the world’s leading enterprise AI video platform. Over 1 million users across 65,000 businesses, including more than 60% of the Fortune 100, use it to communicate efficiently and share knowledge at scale using AI avatars. Founded in 2017, Synthesia is headquartered in London and makes video creation, collaboration and sharing easy for everyone. To learn more, visit www.synthesia.io  

    The MIL Network

  • MIL-OSI: Advanced PMIC for High-Performance AI, Industrial Computing and Data Center Applications

    Source: GlobeNewswire (MIL-OSI)

    CHANDLER, Ariz., April 10, 2025 (GLOBE NEWSWIRE) — The rapid integration of AI into industrial, computing and data center applications is fueling a growing demand for more efficient and advanced power management solutions. Microchip Technology (Nasdaq: MCHP) today announces the MCP16701, a Power Management Integrated Circuit (PMIC) designed to meet the needs of high-performance MPU and FPGA designers. The MCP16701 integrates eight 1.5A buck converters that can be paralleled, four 300 mA internal Low Dropout Voltage Regulators (LDOs) and a controller to drive external MOSFETs.

    This highly integrated device can result in a 48% area reduction with less than 60% of the component count of a discrete solution. The MCP16701 is in a small-form-factor 8 mm × 8 mm VQFN package to offer a compact and flexible power management solution for space-constrained applications. The MCP16701 meets diverse power needs and supports Microchip’s PIC64-GX MPU and PolarFire® FPGAs with a configurable feature set.

    “With the introduction of the MCP16701, Microchip is setting a new standard in PMIC technology by offering an unprecedented level of integration and flexibility,” said Rudy Jaramillo, vice president of Microchip’s analog power and interface division. “This advanced PMIC is designed specifically for high-performance applications, enabling our customers to streamline their design process.”

    The MCP16701 features an I2C communication interface to simplify and enhance communication efficiency between the PMIC and other system components. The device operates within a temperature range of TJ −40°C to +105°C for reliable performance in diverse environmental conditions.

    A key feature of the MCP16701 is its ability to dynamically change Vout levels for all converters in 12.5 mV/25 mV increments. This maximum flexibility allows designers to fine-tune power delivery to meet specific application requirements, helping enhance overall system efficiency and performance.

    The MCP16701 joins a family of Microchip PMIC products—including the MCP16502, MCP16501 and others—that are used to power high-performance MPU applications targeting industrial computing, data centers, IoT and edge AI. To learn more, visit Microchip’s power management products web page.

    Development Tools

    The MCP16701 PMIC is supported by the EV23P28A Evaluation Board and GUI to help developers evaluate their design.

    Pricing and Availability

    The MCP16701 device is available for $3.00 each in 10,000-unit quantities. For additional information and to purchase, contact a Microchip sales representative, authorized worldwide distributor or visit Microchip’s Purchasing and Client Services website, www.microchipdirect.com.

    Resources

    High-res images available through Flickr or editorial contact (feel free to publish):
    • Application image: www.flickr.com/photos/microchiptechnology/54349270613/sizes/l

    About Microchip Technology:
    Microchip Technology Inc. is a leading provider of smart, connected and secure embedded control and processing solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs which reduce risk while lowering total system cost and time to market. The company’s solutions serve over 100,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality. For more information, visit the Microchip website at www.microchip.com.

    Note: The Microchip name and logo, the Microchip logo, PolarFire are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.

    The MIL Network

  • MIL-OSI: Zscaler ThreatLabz 2025 VPN Risk Report: Over Half of Organizations Say Security and Compliance Risks Make VPNs Obsolete

    Source: GlobeNewswire (MIL-OSI)

    Key Findings:

    • 92% of organizations are concerned about ransomware attacks due to VPN vulnerabilities
    • 93% of organizations fear backdoor vulnerabilities from third-party VPN connections
    • 81% of organizations are adopting or planning to adopt zero trust within the next year

    SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today published the Zscaler ThreatLabz 2025 VPN Risk Report, commissioned by Cybersecurity Insiders, which highlights the widespread security, user experience and operational challenges posed by VPN services. The findings are based on insights from a survey of 600+ IT and security professionals. The results are stark: maintaining security and compliance is the single largest challenge (56%) facing enterprises using VPNs today. Meanwhile, the risks of supply chain attacks and ransomware are top of mind for these companies with 92% of respondents concerned that persistent VPN vulnerabilities will lead to ransomware attacks. These combined risks have culminated in a profound shift in thinking around enterprise VPNs with 65% of organizations planning to replace their VPNs within the year — while 81% plan to implement a zero trust everywhere strategy.

    Initially built for remote access, VPNs have become a liability for corporate networks, exposing IT assets and sensitive data due to over-privileged access, vulnerabilities, and an ever-growing attack surface. VPN, both physical and virtual, is opposite of Zero Trust as by architecture it brings the remote users as well as attackers on the network. Additionally, VPNs hinder operational efficiency with slow performance, frequent connection issues, and complex maintenance, burdening IT teams and disrupting employee productivity. The report aims to shed light on these concerns with trusted insights from industry peers, while arming enterprises with guidance to enable secure access across today’s hybrid work environments.

    Security and usability concerns
    Security and compliance risks ranked as the top VPN challenges at 54%, highlighting growing concerns that VPNs are inadequate and obsolete for defending against today’s evolving cyber threats. Cybercriminals are now leveraging AI to pinpoint vulnerabilities by using GPT models to run queries focused on identifying weaknesses in VPNs — for instance, performing reconnaissance by simply asking a generative AI chatbot to return all current CVEs for VPN products in use by an enterprise. Tasks that once required weeks or even months can now be accomplished in just minutes.

    Recently, a foreign cyberespionage group exploited vulnerabilities in a popular VPN, gaining unauthorized access to corporate networks. This incident, one of several in recent months, reinforces how VPN vulnerabilities continue to be a key target in cyberattacks, underscoring the urgent need to transition from legacy security models to a Zero Trust architecture. A staggering 92% of survey respondents said they are concerned about being targeted by ransomware attacks due to unpatched VPN vulnerabilities.

    “Attackers will increasingly leverage AI for automated reconnaissance, intelligent password spraying, and rapid exploit development, allowing them to compromise VPNs at scale,” said Deepen Desai, CSO at Zscaler. “To address these risks, organizations should shift to a Zero Trust everywhere approach. This approach eliminates the need for internet-exposed assets like VPNs (physical and virtual), while drastically reducing the attack surface and potential impact of breaches. It’s encouraging to see that 81% of organizations are planning to implement Zero Trust within the next year—a critical step in mitigating the security risks posed by legacy technologies like VPNs.”

    The rise of critical, scannable VPN vulnerabilities
    To understand how attackers exploit vulnerabilities in internet-connected VPN infrastructure, ThreatLabz also analyzed VPN Common Vulnerabilities and Exposures (CVEs) from 2020-2025, based on data from the MITRE CVE Program. In general, vulnerability reporting is a good thing, as rapid vulnerability disclosure and patching helps the entire ecosystem improve cyber hygiene, foster community collaboration, and quickly respond to new vectors of attack. No type of software is immune from vulnerabilities, nor should it be expected to be.

    Figure 1: The impact type of VPN CVEs from 2020-2024, covering remote code execution (RCE), privilege escalation, DoS, sensitive information leakage, and authentication bypass.

    Over the sample period, VPN CVEs grew by 82.5% (note that early 2025 data has been removed for this portion of the analysis). In the past year, roughly 60% of the vulnerabilities indicated a high or critical CVSS score — indicating a potentially serious risk to impacted organizations. Moreover, ThreatLabz found that vulnerabilities enabling remote code execution (RCE) were the most prevalent kind, in terms of the impact or capabilities they can grant to attackers. These types of vulnerabilities are typically serious, as they can grant attackers the ability to execute arbitrary code on the system. Put another way, far from being innocuous, the bulk of VPN CVEs are leaving their customers vulnerable to critical exploits that attackers can, and often do, exploit.

    Unwelcome party guests
    VPNs provide broad access following authentication, extending user access to contractors, external partners and vendors. While great in theory connectivity tools, attackers can easily exploit weak or stolen credentials, misconfigurations, and unpatched vulnerabilities to compromise these trusted connections. The report shows, 93% of organizations now worry about backdoor vulnerabilities stemming from third-party access. In February 2024, a financial services company suffered a data breach exposing nearly 20,000 clients’ personal information, caused by vulnerabilities in their VPN. This incident highlights how VPNs create exploitable entry points into corporate networks.

    Out with the old, in with the new – Zero Trust Everywhere
    Legacy or traditional vendors are attempting to adapt to the evolving landscape by deploying virtual machines in the cloud and labeling them as Zero Trust solutions. Unfortunately, a VPN hosted in the cloud remains, at its core, a VPN and does not adhere to true Zero Trust principles. Illustrating this point, the industry has recently witnessed massive spikes in scanning activity targeting tens of thousands of publicly searchable VPN IP addresses hosted by at least one of the largest security vendors. Historically, this kind of activity has indicated some likelihood that attackers may be preparing to exploit yet-to-be-disclosed vulnerabilities in targeted VPN assets. Case in point: if you are reachable, you are breachable — which is why, from an architectural perspective, cloud-based VPN technology can never achieve true zero trust principles, no matter the branding.

    The switch to a holistic Zero Trust architecture is rapidly gaining momentum and replacing outdated legacy security tools due to the proven security benefits and efficiency gains for adopting organizations. The report found 81% of organizations are adopting, or planning to adopt, a Zero Trust architecture within the next year and by extending this architecture to users, applications and workloads, enterprises are ensuring that Zero Trust is truly everywhere enabling VPN-free resilient security that:

    1. Minimizes the Attack Surface: Replaces network-based access with Zero Trust policies and identity-based controls to secure users and third parties.
    2. Blocks Threats: Prevents initial compromise through robust authentication, identity security, and least-privileged Zero Trust Access.
    3. Prevents Lateral Movement: Uses Zero Trust segmentation to contain threats and stop unauthorized spread within networks.
    4. Enhances Data Security: Enforces context-aware, integrated Zero Trust policies to protect sensitive information.
    5. Simplifies Operations: Replaces VPNs with AI-driven security, continuous monitoring, and automated policy enforcement, in addition to uninterrupted access with business continuity.

    By adopting these best practices, organizations can replace VPN security risks with a robust Zero Trust framework, enabling continuous verification, least-privileged access, and proactive threat prevention.

    The Zscaler ThreatLabz 2025 VPN Risk Report provides additional insights and best practices to help organizations effectively prevent attacks and ransomware. Download your copy here.

    Research Methodology
    This report is based on a comprehensive survey of 632 IT and cybersecurity professionals conducted by Cybersecurity Insiders. The study examines VPN security risks, enterprise access trends, and the adoption of zero trust architectures. Respondents include executives, IT security practitioners, and network infrastructure leaders across various industries. The findings provide a data-driven perspective on the decline of VPNs and the shift to zero trust, offering critical insights for organizations modernizing their access security strategies.

    About ThreatLabz
    ThreatLabz is the security research arm of Zscaler. This world-class team is responsible for hunting new threats and ensuring that the thousands of organizations using the global Zscaler platform are always protected. In addition to malware research and behavioral analysis, team members are involved in the research and development of new prototype modules for advanced threat protection on the Zscaler platform, and regularly conduct internal security audits to ensure that Zscaler products and infrastructure meet security compliance standards. ThreatLabz regularly publishes in-depth analyses of new and emerging threats on its portal, research.zscaler.com.

    About Zscaler
    Zscaler (NASDAQ: ZS) accelerates digital transformation so customers can be more agile, efficient, resilient, and secure. The Zscaler Zero Trust Exchange™ platform protects thousands of customers from cyberattacks and data loss by securely connecting users, devices, and applications in any location. Distributed across more than 150 data centers globally, the SASE-based Zero Trust Exchange is the world’s largest in-line cloud security platform.

    Media Contact
    Natalia Wodecki
    press@zscaler.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6c9af7e7-b67b-46d5-bfeb-c62a453b507a

    The MIL Network

  • MIL-OSI: Willis appoints Dom Spinelli Head of Transactional Insurance Claims in North America

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) — Willis, a WTW business (Nasdaq: WTW), today announced the appointment of Dom Spinelli as Head of Transactional Insurance Claims for North America. In this role, he will lead the claims function within Willis’ Alternative Asset Insurance Solutions (AAIS) industry vertical division, overseeing the entire lifecycle of transactional insurance claims, including representations and warranties, tax, and contingent matters.

    Spinelli brings 15 years of experience in insurance and litigation to the role, enhancing Willis’ transactional claims capabilities while also supporting the expansion of services for clients navigating complex deal-related risks. Most recently, he served as Head of Contingent & Litigation Risk for North America at VALE Insurance Partners, after leading the contingent legal risk insurance team at Liberty Global Transaction Solutions and working as a representations and warranties insurance underwriter. Earlier in his career, Spinelli was a litigator, managing a wide range of commercial and insurance coverage disputes across the U.S.

    In addition to his litigation background, Spinelli has represented insurers in hundreds of complex claims across nearly every line of insurance. He is the only claims professional with senior-level experience on both the underwriting and claims sides, offering clients a rare and valuable perspective on maximizing outcomes. His expertise will not only enhance Willis’s ability to support clients throughout the claims process, but also provide critical value at the outset of a transaction, helping structure policies appropriately from the start.

    Based in Boston, Spinelli will report to Simone Bonnet, Head of Transactional Insurance Solutions, North America at Willis.

    “Dom’s extensive experience—spanning litigation, underwriting, and claims—gives him a unique ability to guide clients through the most challenging aspects of transactional insurance,” commented Bonnet. “His diverse expertise strengthens our ability to provide innovative and effective solutions. We are excited to have him join the team and look forward to the valuable contributions he will make.”

    Spinelli holds a BA from Providence College and a JD from the University of Connecticut School of Law. He is admitted to practice law in Massachusetts, Connecticut, Illinois, and the Southern and Eastern District Courts of New York.

    About WTW

    At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk, and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce, and maximize performance.

    Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success—and provide perspective that moves you.
    Learn more at wtwco.com.

    Media Contact

    Douglas Menelly
    Douglas.Menelly@wtwco.com | +1 (516) 972-0380

    Arnelle Sullivan
    Arnelle.Sullivan@wtwco.com | +1 (718) 208-0474

    The MIL Network

  • MIL-OSI: American Rebel CEO Andy Ross Appears on Miami TV WSFL – Home of the Florida Panthers and is Featured in the New York Post for his Meetings at Mar-A-Lago as the Brand Continues to Expand its Footprint in Florida 

    Source: GlobeNewswire (MIL-OSI)

    Miami Television Appearance and Investor Meetings at Mar-a-Lago Signal Big Moves for the Nation’s Fast-Growing Beer Brand – American Rebel Light Beer

    Nashville, TN, April 10, 2025 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel (americanrebel.com), is excited to share its CEO Andy Ross’ TV interview on Miami’s WSFL – Home of the Florida Panthers and the New York Post’s coverage of Andy’s meetings with investors and members at Mar-a-Lago, dubbed “The Winter White House.”

    “We had very productive meetings at Mar-a-Lago with like-minded patriots and potential investors,” said Andy Ross, CEO of American Rebel. “Florida is near the top of our list of states we’re planning to expand. We believe Florida will love America’s Patriotic, God Fearing, Constitution Loving, National Anthem Singing, Stand Your Ground Beer. It’s an honor and a blessing to be a guest at Mar-a-Lago and to be launching our beer at what I believe will be a historic time for our country.”

    WSFL interview can be found here:
    From Music to Malts: Andy Ross Brings American Rebel Beer to Florida
    https://www.wsfltv.com/inside-south-florida/from-music-to-malts-andy-ross-brings-american-rebel-beer-to-florida

    New York Post article can be found here:
    https://pagesix.com/2025/04/08/society/celebratory-mood-at-mar-a-lago-despite-market-drop-after-trumps-liberation-day-tariffs-felt-like-a-rally/

    About American Rebel Light Beer

    Produced in partnership with AlcSource, American Rebel Light Beer (americanrebelbeer.com) is a premium domestic light lager celebrated for its exceptional quality and patriotic values. It stands out as America’s Patriotic, God-Fearing, Constitution-Loving, National Anthem-Singing, Stand Your Ground Beer.

    American Rebel Light is a Premium Domestic Light Lager Beer – All Natural, Crisp, Clean and Bold Taste with a Lighter Feel. With approximately 100 calories, 3.2 carbohydrates, and 4.3% alcoholic content per 12 oz serving, American Rebel Light Beer delivers a lighter option for those who love great beer but prefer a more balanced lifestyle. It’s all natural with no added supplements and importantly does not use corn, rice, or other sweeteners typically found in mass produced beers.

    About American Rebel Holdings, Inc.

    American Rebel Holdings, Inc. (NASDAQ: AREB) has operated primarily as a designer, manufacturer and marketer of branded safes and personal security and self-defense products and has recently transitioned into the beverage industry through the introduction of American Rebel Light Beer. The Company also designs and produces branded apparel and accessories. To learn more, visit www.americanrebel.com and www.americanrebelbeer.com. For investor information, visit www.americanrebelbeer.com/investor-relations.

    American Rebel Holdings, Inc.
    info@americanrebel.com

    American Rebel Beverages, LLC
    Todd Porter, President
    tporter@americanrebelbeer.com

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. American Rebel Holdings, Inc., (NASDAQ: AREB; AREBW) (the “Company,” “American Rebel,” “we,” “our” or “us”) desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “forecasts” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements primarily on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include benefits of marketing outreach efforts, actual placement timing and availability of American Rebel Beer, success and availability of the promotional activities, our ability to effectively execute our business plan, and the Risk Factors contained within our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2024. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.

    Company Contact:
    tporter@americanrebelbeer.com
    ir@americanrebel.com

    Media Contact:
    Matt Sheldon
    Matt@PrecisionPR.co

    Attachments

    The MIL Network

  • MIL-OSI: Cerence AI Honored with HARMAN’s Best Technology Award

    Source: GlobeNewswire (MIL-OSI)

    BURLINGTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that it has been awarded the Best Technology Award by HARMAN during its Supplier Awards event held in Budapest. This recognition underscores Cerence AI’s commitment to delivering cutting-edge AI solutions that enhance the in-car experience.

    The Supplier Awards event celebrates HARMAN’s exceptional suppliers who have significantly contributed to HARMAN’s resilience, collaboration, and innovation across its global supply chain. Cerence AI was honored in the Best Technology Award category in recognition of the companies’ long-term, successful collaboration on innovations shaping the future of automotive technology.

    Most recently, at CES 2025, HARMAN introduced its “Luna” avatar powered by Ready Engage, HARMAN’s new emotionally intelligent AI system designed to transform in-car experiences. This system features pre-integration with Cerence AI’s voice assistant, offering personalized AI-powered interactions that anticipate needs and respond naturally through voice and visuals. In addition, the companies integrated Cerence AI’s CaLLM™ Edge SLM, powered by Microsoft, into HARMAN’s Ready Upgrade, making it easier for third-party app developers to create in-car applications that bring consumers’ preferred, personalized content into the vehicle while ensuring that personal data remains secure.

    “We are honored to receive the Best Technology Award from HARMAN, a testament to our ongoing collaboration and shared vision for the future of in-car experiences,” said Christian Mentz, Chief Revenue Officer, Cerence AI. “This recognition reflects our dedication to pushing the boundaries of AI to create intuitive and intelligent interactions between drivers and their vehicles.”

    “The HARMAN Supplier Awards was more than a celebration—it was a powerful reminder of what we can achieve when we move as one with our partners,” said Dave Parker, Senior Vice President, Procurement and Best Cost Analytics, HARMAN. “These recognitions reflect the shared pursuit of excellence that drives our industry forward and we are proud to recognize Cerence AI for its innovative technology and continued collaboration.”

    To learn more about Cerence AI, visit www.cerence.ai, and follow the company on LinkedIn.

    About Cerence Inc.
    Cerence Inc. (NASDAQ: CRNC) is a global industry leader in creating intuitive, seamless, AI-powered experiences across automotive and transportation. Leveraging decades of innovation and expertise in voice, generative AI, and large language models, Cerence powers integrated experiences that create safer, more connected, and more enjoyable journeys for drivers and passengers alike. With more than 500 million cars shipped with Cerence technology, the company partners with leading automakers, transportation OEMs, and technology companies to advance the next generation of user experiences. Cerence is headquartered in Burlington, Massachusetts, with operations globally and a worldwide team dedicated to pushing the boundaries of AI innovation. For more information, visit www.cerence.ai.

    Contact Information

    Kate Hickman | Tel: 339-215-4583 | Email: kate.hickman@cerence.com

    The MIL Network

  • MIL-OSI: TransUnion’s OneTru™ Accelerates Product Innovation, Delivering Exceptional Results

    Source: GlobeNewswire (MIL-OSI)

    CHICAGO, April 10, 2025 (GLOBE NEWSWIRE) — One year ago, TransUnion (NYSE: TRU) introduced its transformative OneTru™ solution enablement platform for managing, governing, analyzing and delivering data, identity and insights. Today, OneTru delivers on its promises, accelerating and expanding the pace and breadth of the company’s innovation.

    Over the course of 2024 and early 2025, OneTru capabilities have powered several of TransUnion’s B2B product lines:

    • TransUnion’s alternative lending bureau is now enabled by OneTru, leading to new and enhanced solutions, including TruVision credit risk products that enrich lenders’ existing underwriting scores.
    • Identity capabilities for the TruAudience line of products have been unified on OneTru, enabling more persistent views of identity whether planning, executing or measuring marketing efforts.
    • TruValidate fraud solutions powered by the platform have improved fraud capture rates and decreased manual reviews and false positives.

    OneTru is currently operational in the U.S. and India, and TransUnion plans to expand the platform soon to Canada, the Philippines and the U.K.

    “We continue to build on OneTru’s success by expanding its underlying capabilities, including identity attributes, enhanced matching, decisioning and AI tools to improve efficiency,” said Chris Cartwright, President and CEO, TransUnion. “Our progress enhances the performance of our seven global product lines, delivering better overall quality and accelerating time-to-insights for our customers.”

    Products Powered by OneTru Deliver Better Customer Results

    In just one year, products powered by the OneTru platform have delivered better results for customers:

    • A major financial institution increased their fraud capture rates by 162% using TruValidate fraud solutions.
    • A FinTech leveraged the TruIQ Analytics Studio to build lending models in near real-time, reducing development time from 10 hours to less than one hour.
    • A U.S. credit card issuer cut its offer timeline from 45 to 21 days using TruIQ Data Enrichment.
    • A leading retailer enhanced its marketing data using TruAudience Identity Enrichment to capture insights from over 100 million daily interactions and maintain a fresh view of over 90 million active customers.

    “Many customer benefits from OneTru stem from our Customer Zero approach, where we internally test new and exciting capabilities before releasing them through our product lines,” said Venkat Achanta, Chief Technology, Data & Analytics Officer at TransUnion. “For instance, our AI capabilities are expanding to enable autonomous decision-making, adaptive learning and proactive execution. We expect that these advancements will support use cases such as audience segmentation, predictive scoring and identity resolution, leading to greater innovation for both the company and our customers.”

    To secure access to an upcoming TransUnion roundtable discussion with Forrester about the future uses of AI and other technology trends, please click here. More information about TransUnion’s solution lines can be found here.

    About TransUnion (NYSE: TRU)

    TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As a result, consumers and businesses can transact with confidence and achieve great things. We call this Information for Good® — and it leads to economic opportunity, great experiences and personal empowerment for millions of people around the world.

    http://www.transunion.com/business

    Contact Dave Blumberg
    TransUnion
    Telephone 312-972-6646
    E-mail david.blumberg@transunion.com

    The MIL Network

  • MIL-OSI: Byrna Technologies Fiscal First Quarter 2025 Results

    Source: GlobeNewswire (MIL-OSI)

    ANDOVER, Mass., April 10, 2025 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today reported select financial results for its fiscal first quarter (“Q1 2025”) ended February 28, 2025.

    Fiscal First Quarter 2025 and Recent Operational Highlights

    • Launched Byrna’s first store-within-a-store concept at Sportsman’s Warehouse flagship location in Saratoga Springs, Utah, with 12 additional locations expected to open by early May.
    • Opened three company-owned retail stores in high-foot-traffic areas in the Greater Nashville Area, Scottsdale, Arizona, and Salem, New Hampshire, generating between $1,000 and $1,700 in daily sales per store in their first full month of operation. A fourth store in Fort Wayne, Indiana is opening today.
    • Increased launcher production capacity by 33% to 24,000 launchers per month and began producing payload ammo rounds at its new Fort Wayne ammo facility, capable of producing 8 million rounds per year.
    • Strengthened domestic sourcing, achieving 92% U.S.-made components for Byrna’s flagship model, the Byrna SD, as part of Byrna’s ongoing ‘Made in America’ initiative.
    • Partnered with celebrity influencers Charlie Kirk, Megyn Kelly, Lara Trump, and Donald Trump Jr. to amplify brand awareness and promote the normalization of less-lethal solutions, while continuing to optimize marketing spend for maximum impact.

    Fiscal First Quarter 2025 Financial Results
    Results compare Q1 2025 to the 2024 fiscal first quarter ended February 29, 2024 unless otherwise indicated.

    Net revenue for Q1 2025 grew 57% year-over-year to $26.2 million from $16.7 million in the fiscal first quarter of 2024 (“Q1 2024”). The strong year-over-year growth was primarily attributable to continuing sales momentum, channel expansion, and broader brand adoption.

    Gross profit for Q1 2025 increased to $15.9 million (61% of net revenue) from $9.6 million (58% of net revenue) in Q1 2024. The increase in gross profit was driven by a reduction in component costs driven by a mid-2024 initiative focused on “design for manufacturability” and the economies of scale resulting from increased production volumes.

    Operating expenses for Q1 2025 were $14.2 million, compared to $9.8 million for Q1 2024. The increase was primarily due to higher variable selling expenses, payroll costs, and increased discretionary marketing spend.

    Net income for Q1 2025 was $1.7 million, a significant improvement from $17,000 for Q1 2024. This increase was driven by an overall increase in product sales.

    Adjusted EBITDA1, a non-GAAP metric reconciled below, for Q1 2025 totaled $2.8 million, compared to $1.2 million in Q1 2024.

    Cash, cash equivalents and marketable securities at February 28, 2025 totaled $19.3 million compared to $25.7 million at November 30, 2024. The decrease reflects planned increases in inventory ahead of the Compact Launcher release and normal seasonal working capital movements. Inventory at February 28, 2025 totaled $23.2 million compared to $20.0 million at November 30, 2024. The Company has no current or long-term debt.

    Management Commentary
    Byrna CEO Bryan Ganz stated: “We delivered a strong start to the fiscal year with 57% revenue growth and our second-highest quarter ever, only 6% below our record $28 million Q4, despite Q1 traditionally being our slowest seasonal period. The strong results reflect continuing sales momentum, increasing adoption of less-lethal self-defense options, and rising brand visibility. As expected, January sales softened due to post-holiday consumer fatigue and waning consumer confidence; however, we saw daily sales improve month-over-month in both February and March. Looking ahead, we believe our performance will continue to be supported by Byrna’s expanding retail footprint, growing Amazon presence, and sustained awareness-building efforts – all of which lay the groundwork for the upcoming Compact Launcher release.

    “We launched our first store-within-a-store at Sportsman’s flagship store in Saratoga Springs, Utah in March, and the partnership is off to a strong start. Byrna products are expected to be available in 12 additional store-within-a-store locations by early May as part of our 13-store pilot program. Each location will be supported by a Byrna representative during the rollout period to help ensure the strongest possible launch. Sportsman’s has demonstrated a strong commitment to the partnership, and we are jointly funding the buildout, with Byrna covering half of the roughly $15,000 cost per installation. Depending on store layout, these store-within-a-store locations will either include a Byrna-branded firing range – converted from a former archery bay – or a self-contained shooting lane with dedicated display cases and shelf space. Separately, Sportsman’s plans to add Byrna point-of-sale displays at an additional 41 locations, which will also include a Byrna shooting experience.

    “Assuming that these stores perform similarly to Byrna’s retail stores, Sportsman’s intends to continue opening the Byrna store-within-a-store installations in additional stores. Based on the early performance of the initial stores, we could expand to approximately 30 store-within-a-store locations by the end of August, with a goal of reaching 50 by year-end and potentially adding another 50 in 2026.

    “At the same time, we opened three company-owned stores in Q1. While our current emphasis is on capital-efficient retail expansion through partnerships like Sportsman’s, we remain excited about the long-term potential of Byrna-branded stores, particularly in regions not served by our retail partners. Additionally, these stores act as flagship stores for Byrna, where we can run training programs, host celebrities, and bring in local groups. Early results for the new stores have exceeded expectations, with daily sales averaging between $1,000 and $1,700 per store. These locations have proven especially effective at reaching first-time Byrna customers, and we’re seeing strong walk-in traffic and local engagement. As we evaluate our broader retail strategy, these stores continue to provide valuable insights into consumer behavior and brand building in high-foot-traffic areas.

    “On the operations front, we increased monthly launcher production capacity to 24,000 units across four active production lines. In the first quarter, we built inventory across our SD and LE platforms in preparation for the launch of the Compact Launcher. While the ultimate launcher mix remains to be seen, our Fort Wayne factory has the flexibility to shift production between CL, SD, and LE models based on real-time demand.

    “In March, we also began producing payload rounds at our new ammunition manufacturing facility in Fort Wayne, Indiana, which has the capacity to produce up to 8 million rounds annually. Several machines are already operational, with additional machines coming online over the next few months to support future volume growth. We also have four additional dosing and welding machines on order as we expect to see significant increases in ammo demand with the release of the Compact Launcher, particularly as the CL uses a .61 caliber round which will only be available from Byrna for the foreseeable future.

    “As part of our commitment to domestic manufacturing, we’ve made significant progress with our ‘Made in America’ initiative. Today, 92% of the components used in the manufacture of our flagship SD launcher are sourced from U.S. suppliers, which is up from just 34% a few months ago. We remain on track to exceed 90% domestic sourcing for all products by the end of 2025, a milestone that enhances our supply chain reliability, reduces tariff risk, and supports our brand story.

    “We continued to refine our roster of celebrity and influencer partners, recently adding personalities such as Megyn Kelly, Charlie Kirk, Lara Trump, and Donald Trump Jr. to our existing lineup. These partnerships support our strategy to normalize the category and reach new audiences across demographic segments.

    “In financial matters, we expect our effective tax rate to increase to approximately 23% in 2025 as we transition into full taxpayer status. Our balance sheet remains strong, and while we expect some working capital investment in Q2 as inventory builds ahead of the CL launch, we will very quickly start turning the inventory into cash once the launcher is released. Accordingly, we anticipate continued cash generation in the second half of the year.

    “With momentum across our channels, scalable partnerships in place, and a highly anticipated new product on the horizon, we remain confident in our ability to continue to execute through 2025 and beyond.”

    Conference Call
    The Company’s management will host a conference call today, April 10, 2025, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) to discuss these results, followed by a question-and-answer period.

    Toll-Free Dial-In: 877-709-8150
    International Dial-In: +1 201-689-8354
    Confirmation: 13752594

    Please call the conference telephone number 5-10 minutes prior to the start time of the conference call. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 949-574-3860.

    The conference call will be broadcast live and available for replay here and via the Investor Relations section of Byrna’s website.

    About Byrna Technologies Inc.
    Byrna is a technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions. For more information on the Company, please visit the corporate website here or the Company’s investor relations site here. The Company is the manufacturer of the Byrna® SD personal security device, a state-of-the-art handheld CO2 powered launcher designed to provide a less-lethal alternative to a firearm for the consumer, private security, and law enforcement markets. To purchase Byrna products, visit the Company’s e-commerce store.

    Forward-Looking Statements
    This news release contains “forward-looking statements” within the meaning of the securities laws. All statements contained in this news release, other than statements of current and historical fact, are forward-looking. Often, but not always, forward-looking statements can be identified by the use of words such as “plans,” “expects,” “intends,” “anticipates,” and “believes” and statements that certain actions, events or results “may,” “could,” “would,” “should,” “might,” “occur,” or “be achieved,” or “will be taken.” Forward-looking statements include descriptions of currently occurring matters which may continue in the future. Forward-looking statements in this news release include but are not limited to our statements related to our expected sales during 2025, our ability to scale production lines, Byrna’s ability to remain self-sustaining, profitable and cash flow positive, Byrna’s ability to open new retail locations and realize revenue growth from them, the expected scale, timing and benefits of Byrna’s store-within-a-store partnership with Sportsman’s Warehouse, the benefits and continued success of Byrna’s celebrity endorser strategy, Byrna’s ability to re-shore production and cease purchasing parts from China on the anticipated timeline, the expected benefits of re-shoring production, the anticipated growth and potential size of the U.S. less-lethal market, and Byrna’s positioning for sustained growth in 2025 and 2026. Forward-looking statements are not, and cannot be, a guarantee of future results or events. Forward-looking statements are based on, among other things, opinions, assumptions, estimates, and analyses that, while considered reasonable by the Company at the date the forward-looking information is provided, inherently are subject to significant risks, uncertainties, contingencies, and other factors that may cause actual results and events to be materially different from those expressed or implied.

    Any number of risk factors could affect our actual results and cause them to differ materially from those expressed or implied by the forward-looking statements in this news release, including, but not limited to, disappointing market responses to current or future products or services; prolonged, new, or exacerbated disruption of our supply chain; the further or prolonged disruption of new product development; production or distribution disruption or delays in entry or penetration of sales channels due to inventory constraints, competitive factors, increased transportation costs or interruptions, including due to weather, flooding or fires; prototype, parts and material shortages, particularly of parts sourced from limited or sole source providers; determinations by third party controlled distribution channels, including Amazon, not to carry or reduce inventory of the Company’s products; determinations by advertisers or social media platforms, or legislation that prevents or limits marketing of some or all Byrna products; the loss of marketing partners; increases in marketing expenditure may not yield expected revenue increases; potential cancellations of existing or future orders including as a result of any fulfillment delays, introduction of competing products, negative publicity, or other factors; product design or manufacturing defects or recalls; litigation, enforcement proceedings or other regulatory or legal developments; changes in consumer or political sentiment affecting product demand; regulatory factors including the impact of commerce and trade laws and regulations; and future restrictions on the Company’s cash resources, increased costs and other events that could potentially reduce demand for the Company’s products or result in order cancellations. The order in which these factors appear should not be construed to indicate their relative importance or priority. We caution that these factors may not be exhaustive; accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. Investors should carefully consider these and other relevant factors, including those risk factors in Part I, Item 1A, (“Risk Factors”) in the Company’s most recent Form 10-K and Part II, Item 1A (“Risk Factors”) in the Company’s most recent Form 10-Q, should understand it is impossible to predict or identify all such factors or risks, should not consider the foregoing list, or the risks identified in the Company’s SEC filings, to be a complete discussion of all potential risks or uncertainties, and should not place undue reliance on forward-looking information. The Company assumes no obligation to update or revise any forward-looking information, except as required by applicable law.

    Investor Contact:
    Tom Colton and Alec Wilson
    Gateway Group, Inc.
    949-574-3860
    BYRN@gateway-grp.com

    -Financial Tables to Follow-

             
    BYRNA TECHNOLOGIES INC.
    Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
    (Amounts in thousands except share and per share data)
    (Unaudited)
             
        For the Three Months Ended
        February 28
          2025       2024  
    Net revenue   $ 26,190     $ 16,654  
    Cost of goods sold     10,266       7,015  
    Gross profit     15,924       9,639  
    Operating expenses     14,228       9,803  
    INCOME (LOSS) FROM OPERATIONS     1,696       (164 )
    OTHER INCOME (EXPENSE)        
    Foreign currency transaction loss     (80 )     (58 )
    Interest income     186       280  
    Loss from joint venture           (42 )
    Other income (expense)           1  
    INCOME (LOSS) BEFORE INCOME TAXES     1,802       17  
    Income tax expense     (140 )      
    NET INCOME (LOSS)   $ 1,662     $ 17  
             
    Foreign currency translation adjustment for the period     (130 )     (115 )
    Unrealized gain on marketable securities     60        
    COMPREHENSIVE INCOME (LOSS)   $ 1,592     $ (98 )
             
    Basic net income (loss) per share   $ 0.07     $ 0.00  
    Diluted net income (loss) per share   $ 0.07     $ 0.00  
             
    Weighted-average number of common shares outstanding – basic     22,587,099       22,035,249  
    Weighted-average number of common shares outstanding – diluted     24,098,635       22,838,827  
             
             
    BYRNA TECHNOLOGIES INC.
    Condensed Consolidated Balance Sheets
    (Amounts in thousands, except share and per share data)
             
        February 28   November 30,
          2025       2024  
        Unaudited    
    ASSETS        
    CURRENT ASSETS        
    Cash and cash equivalents   $ 7,669     $ 16,829  
    Marketable Securities     11,620       8,904  
    Accounts receivable, net     2,900       2,630  
    Inventory, net     23,182       19,972  
    Prepaid expenses and other current assets     3,441       2,623  
    Total current assets     48,812       50,958  
    LONG TERM ASSETS        
    Deposits for equipment     3,669       2,665  
    Right-of-use-asset, net     2,218       2,452  
    Property and equipment, net     4,651       3,408  
    Intangible assets, net     3,273       3,337  
    Goodwill     2,258       2,258  
    Deferred tax asset     5,468       5,837  
    Other assets     689       1,007  
    TOTAL ASSETS   $ 71,038     $ 71,922  
             
    LIABILITIES        
    CURRENT LIABILITIES        
    Accounts payable and accrued liabilities   $ 11,183     $ 13,108  
    Operating lease liabilities, current     572       539  
    Deferred revenue, current     482       1,791  
    Total current liabilities     12,237       15,438  
    LONG TERM LIABILITIES        
    Deferred revenue, non-current     11       17  
    Operating lease liabilities, non-current     1,963       2,098  
    Total liabilities     14,211       17,553  
             
             
    STOCKHOLDERSEQUITY        
    Preferred stock            
    Common stock     25       25  
    Additional paid-in capital     133,895       133,029  
    Treasury stock     (21,253 )     (21,253 )
    Accumulated deficit     (55,121 )     (56,783 )
    Accumulated other comprehensive loss     (719 )     (649 )
             
    Total Stockholders’ Equity     56,827       54,369  
             
    TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 71,038     $ 71,922  
             

    Non-GAAP Financial Measures

    In addition to providing financial measurements based on generally accepted accounting principles in the United States (GAAP), we provide an additional financial metric that is not prepared in accordance with GAAP (non-GAAP) with presenting non-GAAP adjusted EBITDA. Management uses this non-GAAP financial measure, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate our financial performance. We believe that this non-GAAP financial measure helps us to identify underlying trends in our business that could otherwise be masked by the effect of certain expenses that we exclude in the calculations of the non-GAAP financial measure.

    Accordingly, we believe that this non-GAAP financial measure reflects our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business and provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects.

    This non-GAAP financial measure does not replace the presentation of our GAAP financial results and should only be used as a supplement to, not as a substitute for, our financial results presented in accordance with GAAP. There are limitations in the use of non-GAAP measures, because they do not include all the expenses that must be included under GAAP and because they involve the exercise of judgment concerning exclusions of items from the comparable non-GAAP financial measure. In addition, other companies may use other non-GAAP measures to evaluate their performance, or may calculate non-GAAP measures differently, all of which could reduce the usefulness of our non-GAAP financial measure as a tool for comparison.

    Adjusted EBITDA

    Adjusted EBITDA is defined as net (loss) income as reported in our condensed consolidated statements of operations and comprehensive (loss) income excluding the impact of (I) depreciation and amortization; (ii) income tax provision (benefit); (iii) interest income (expense); (iv) stock-based compensation expense, (v) impairment loss, and (vi) one time, non-recurring other expenses or income. Our Adjusted EBITDA measure eliminates potential differences in performance caused by variations in capital structures (affecting finance costs), tax positions, the cost and age of tangible assets (affecting relative depreciation expense) and the extent to which intangible assets are identifiable (affecting relative amortization expense). We also exclude certain one-time and non-cash costs. Reconciliation of Adjusted EBITDA to net (loss) income, the most directly comparable GAAP measure, is as follows (in thousands):

          For the Three Months Ended
          February 28
            2025       2024  
    Net Income (Loss)   $ 1,662     $ 17  
               
    Adjustments:        
      Interest income     (186 )     (280 )
      Income tax expense     140        
      Depreciation and amortization     185       338  
    Non-GAAP EBITDA   $ 1,801     $ 75  
               
    Stock-based compensation expense     840       938  
    Severance/Separation/Officer recruiting     130       163  
    Non-GAAP adjusted EBITDA   $ 2,771     $ 1,176  
               

    1 See non-GAAP financial measures at the end of this press release for a reconciliation and a discussion of non-GAAP financial measures.

    The MIL Network

  • MIL-OSI: STMicroelectronics details company-wide program to reshape manufacturing footprint and resize global cost base

    Source: GlobeNewswire (MIL-OSI)

    PR No: C3330C

    STMicroelectronics details company-wide program to reshape manufacturing footprint and resize global cost base

    • Increasing efficiency, automation, and AI will strengthen ST’s key technology R&D, design and high-volume assets for advanced manufacturing in Europe.
    • Planned investments over FY2025, 2026 and 2027 to focus on advanced manufacturing infrastructure in 300mm silicon, 200mm silicon carbide, and technology R&D, for the benefit of customers globally.
    • Company-wide program, including both the previously disclosed resizing of cost base and the reshaping of manufacturing footprint, expected to see up to 2,800 people leaving the company globally on a voluntary basis over 3 years, on top of normal attrition.
    • Confirmation of annual cost savings target in the high triple-digit million-dollar range exiting 2027.

    Geneva, April 10, 2025 – STMicroelectronics N.V. (“ST”) (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, today disclosed further elements of its program to reshape its global manufacturing footprint. This comes as part of the program announced in October 2024 to further strengthen ST’s competitiveness, solidify its position as a global semiconductor leader, and ensure the long-term sustainability of its model as an Integrated Device Manufacturer by leveraging strategic assets globally across technology R&D, design and high-volume manufacturing. 

    Jean-Marc Chery, President and CEO of STMicroelectronics said: “The reshaping of our manufacturing footprint announced today will future proof our Integrated Device Manufacturer model with strategic assets in Europe and improve our ability to innovate even faster, benefitting all our stakeholders. As we focus on advanced manufacturing infrastructure and mainstream technologies, we will continue to leverage all of our existing sites and bring redefined missions for some of them to support their long-term success. We are committed to managing this program responsibly, according to our long-established values, and exclusively through voluntary measures. The technology R&D, design, and high-volume manufacturing activities in Italy and France will continue to be central to our global operations and will be reinforced via planned investments in mainstream technologies”.

    Innovating and scaling up to increase efficiency across manufacturing operations

    As innovation cycles shorten, ST’s manufacturing strategy is evolving to accelerate the delivery of innovative, proprietary technologies and products at scale to customers globally, across automotive, industrial, personal electronics and communication infrastructure applications.

    The reshaping and modernization of ST’s manufacturing operations aim to achieve two main objectives: prioritizing planned investments towards future-ready infrastructure such as 300mm silicon and 200mm silicon carbide wafer fabs to enable them to reach a critical scale and maximizing the productivity and efficiency of legacy 150mm capabilities and mature 200mm capabilities. In parallel, ST plans to continue to invest in upgrading the technology used across its operations, deploying additional AI and automation for additional efficiency in technology R&D, manufacturing, reliability and qualification processes, with a continued focus on sustainability. 

    Strengthening ST’s manufacturing ecosystem

    Over the next three years, the reshaping of ST’s manufacturing footprint will design and strengthen ST’s complementary ecosystems: in France around digital technologies, in Italy around analog and power technologies and in Singapore on mature technologies. The optimization of these operations aim to achieve full capacity utilization and drive technological differentiation to compete globally. As announced previously, each of ST’s current sites will continue to play a long-term role within the company’s global operations. 

    Building 300mm silicon megafabs in Agrate and Crolles

    The Agrate (Italy) 300mm fab will continue to be scaled up, with the aim to become ST’s flagship high-volume manufacturing facility for smart power and mixed signal technologies. The plan is to double its current capacity to 4,000 wafers per week (wpw) by 2027, with planned modular expansions increasing capacity up to 14,000 wpw, depending on market conditions. As we increase our focus on 300mm manufacturing, the Agrate 200mm fab will refocus on MEMS.
    The Crolles (France) 300mm fab will be further cemented as the core of ST’s digital products ecosystem. The plan is to increase capacity to 14,000 wpw by 2027 with planned modular expansions increasing capacity up to 20,000 wpw, depending on market conditions. In addition, we will convert the Crolles 200mm fab to support Electrical Wafer Sorting high volume manufacturing and advanced packaging technologies, hosting activities that do not exist today in Europe. The focus will be on next-generation leading technologies including optical sensing and silicon photonics.

    Specialized Manufacturing and Competence Center for Power Electronics in Catania

    Catania will continue to serve as a center of excellence for power and wide-bandgap semiconductor devices. The development of the new Silicon Carbide Campus is progressing as planned, with production of 200mm wafers set to begin in Q4 2025, reinforcing ST’s leadership in next-generation power technologies. Our resources supporting Catania’s current 150mm and EWS capabilities will be refocused on 200mm silicon carbide and silicon power semiconductor production, including GaN-on-silicon, reinforcing ST’s leadership in next-generation power technologies.

    Optimizing Other Manufacturing Sites

    Rousset (France) will remain focused on 200mm manufacturing, with additional volumes reallocated from other sites enabling full saturation of existing manufacturing capacity for optimized efficiency.

    Tours (France) will remain focused on its 200mm silicon production line for select technologies, while other activities – including legacy 150mm manufacturing activities – will be transferred to different ST sites, and it will also remain a center of competence for GaN, mainly on epitaxy. The Tours site will also host a new activity: panel-level-packaging, one of the major enablers of chiplets, a technology for complex semiconductor applications that will be key for ST in the future.

    Ang Mo Kio (Singapore), ST’s high-volume fab for mature technologies, will remain focused on 200mm silicon manufacturing and will also host our consolidated global legacy 150mm silicon capabilities.

    Kirkop (Malta), ST’s high-volume test and packaging fab in Europe will be upgraded, with the addition of advanced automated technologies which will be key to support next-generation products.

    Workforce and skills evolution

    As ST reshapes its manufacturing footprint over the next three years, the workforce size and required skill sets will evolve. Advanced manufacturing will shift roles from legacy processes involving repetitive manual tasks to a stronger focus on process control, automation, and design. ST will manage this transition through voluntary measures, with a continued commitment to ongoing constructive dialogue and negotiations with employee representatives in accordance with applicable national regulations. Based on current projections, the program is expected to see up to 2,800 people leaving the company globally on a voluntary basis, on top of normal attrition. These changes are expected to occur mainly in 2026 and 2027. Regular updates will be provided to stakeholders as the program progresses. 

    About STMicroelectronics

    At ST, we are 50,000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. An integrated device manufacturer, we work with more than 200,000 customers and thousands of partners to design and build products, solutions, and ecosystems that address their challenges and opportunities, and the need to support a more sustainable world. Our technologies enable smarter mobility, more efficient power and energy management, and the wide-scale deployment of cloud-connected autonomous things. We are on track to be carbon neutral in all direct and indirect emissions (scopes 1 and 2), product transportation, business travel, and employee commuting emissions (our scope 3 focus), and to achieve our 100% renewable electricity sourcing goal by the end of 2027. Further information can be found at www.st.com.

    For further information, please contact:

    INVESTOR RELATIONS:
    Jérôme Ramel
    EVP Corporate Development & Integrated External Communication
    Tel: +41 22 929 59 20
    jerome.ramel@st.com

    MEDIA RELATIONS:
    Alexis Breton
    Corporate External Communications
    Tel: + 33 6 59 16 79 08
    alexis.breton@st.com

    Attachment

    The MIL Network

  • MIL-OSI: Konsolidator enters partnership with Exsitec to accelerate growth in the Nordics

    Source: GlobeNewswire (MIL-OSI)

    Press release no. 1-2025
    Copenhagen, April 10, 2025

    Konsolidator enters partnership with Exsitec to accelerate growth in the Nordics

    Today, Konsolidator enters a new strategic partnership with Exsitec AB, one of the most prominent players in the Nordic region, to implement and manage business-supporting IT systems. The partnership allows Konsolidator to be fully partner-driven in Sweden and Norway, thereby significantly advancing the company’s 2025–2027 strategy, Resilient Growth, which prioritizes scaling growth through strategic partnerships.

    Exsitec, a long-standing customer of Konsolidator, brings in-depth product knowledge and integration experience. Furthermore, with shared customers and strong expertise in finance IT, Exsitec is an ideal partner for making Konsolidator available to more companies in the Nordics, especially in the mid-market to the enterprise segment.

    “Exsitec’s portfolio, market position, and finance IT expertise make them a great partner for us and fit perfectly into our partner channel strategy. We are now well covered in Denmark, Sweden, and Norway.says Claus Finderup Grove, CEO of Konsolidator

    Konsolidator’s cloud-based consolidation tool automates every step of the group reporting process, from data collection to reporting, ensuring compliance and eliminating Excel-based workflows. The system integrates seamlessly with leading financial platforms like Visma.net, Fortnox, and Microsoft Dynamics 365. Exsitec is a Nordic company with over 20 offices and over 5500 customers in Sweden, Norway, Denmark, and Finland. This partnership is aligned with Konsolidator’s goal of becoming a leader in the Nordic market for automated group reporting and cloud-based financial solutions.

    “We have long supported our customers with advisory, implementation, and managing of IT systems for operational and financial analysis and planning. With Konsolidator, we can now also help CFOs and controllers take ownership of legal group reporting – in a way that is quick to implement, easy to scale, and fully cloud-based. A lot of our customers already use Konsolidator and we use it internally for Exsitec’s group reporting as well, so we are very familiar with it.” says Rasmus Toivonen, Delivery Area Manager at Exsitec.

    2025-2027 Strategy: Towards a partner-driven sales model

    As part of the 2025-2027 strategy, Resilient Growth, Konsolidator is broadening its sales strategy beyond direct sales by leveraging strategic partnerships and ecosystems. This includes a focused expansion of the partner channel, particularly in Scandinavia and Iberia.

    This partnership marks a key milestone in Konsolidator’s transition to a partner-driven model, which can accelerate the company’s efforts to increase its presence and offerings in larger markets.

    Contacts 

    About Konsolidator
    Konsolidator A/S is a financial consolidation software company whose primary objective is to make Group CFOs around the world better through automated financial consolidation and reporting in the cloud. Created by CFOs and auditors and powered by innovative technology, Konsolidator removes the complexity of financial consolidation and enables the CFO to save time and gain actionable insights based on key performance data to become a vital part of strategic decision-making. Konsolidator was listed at Nasdaq First North Growth Market Denmark in 2019. Ticker Code: KONSOL

    Attachment

    The MIL Network

  • MIL-OSI: Eviden signs a 50-million-euro contract to build Serbia’s National AI Factory

    Source: GlobeNewswire (MIL-OSI)

    Eviden will bring together a unique comprehensive set of AI capabilities – supercomputing power for AI, software layer and AI use-cases development

    Paris, France – April 10, 2025 – Eviden, the Atos Group business leading in digital, cloud, big data and security today announces the signature of a 50-million-euro contract with the Serbia’s Office for IT and eGovernment. Together, Eviden and the Serbian administration will deploy a National AI Factory – composed of an AI Center of Excellence and a leading AI-dedicated supercomputing platform – aiming to accelerate Serbia’s AI capabilities and foster innovation across key sectors while reinforcing its technological autonomy using European technologies.

    More than just a simple infrastructure, an AI Factory is an extensive and complete set of shared AI-dedicated assets – talents, expertise, software, hardware – to foster AI innovation and growth, to democratize its use and to drive successful large-scale projects. By providing all necessary resources with European technologies through this single contract, Eviden will empower Serbia to address the growing challenges and requirements of AI.

    This new National AI Factory, a first in the Balkan region, will integrate cutting-edge supercomputing resources, advanced software layers and specialized vertical expertise for use-case design and deployment. This dynamic ecosystem will be made accessible to Serbian public institutions, academic players and businesses in order to harness the power of AI and address critical challenges in health, energy, transportation and administration.

    To meet Serbia’s needs for computing power, Eviden will deploy its BullSequana XH3000 supercomputer, designed and manufactured in its French flagship factory. With up to 25 PetaFlops of computational power – the equivalent of 25 million billion operations per second – as well as 300 GPUs and 2.5 Petabytes of storage, this AI supercomputer will serve as the backbone of this AI Center of Excellence, providing the necessary computing power to develop and run innovative AI use cases.

    In addition to this AI-dedicated hardware, the project will see the implementation of Eviden’s BullSequana AI platform, designed to accelerate AI applications development. The Eviden software layer will integrate Mistral AI assets who brings its leading European GenAI models to help drive groundbreaking use cases.

    This combination of hardware and software capabilities will be complemented by a vertical AI expertise drawn from Eviden’s teams in France, Czech Republic and Serbian AI ecosystem. These AI specialists will bring their deep understanding of sector-specific needs, ensuring an effective application of AI to Serbia’s strategic sectors. They will also assist in recruiting and training engineers and academics across Serbia, ensuring the AI Center of Excellence becomes a self-sustaining hub for innovation.

    Mihailo Jovanovic PhD, Director of the Office for IT and eGovernment, Government of the Republic of Serbia said “This partnership with Eviden, Europe’s leading supercomputing and AI player, is a historic moment for our country’s digital future, demonstrating the spirit of Franco-Serbian cooperation. It is not just a technological leap but a statement of our commitment to foster innovation, advanced our economy and strengthen our position as regional leader in AI. This project is a key step towards implementing Serbia’s vision in accordance with “Leap into the Future – Serbia 2027” Program and plans for further modernization, digitalization, and the application of artificial intelligence.”

    Emmanuel Le Roux, Head of Advanced Computing, Eviden, Atos Group said “With its investment and current leading responsibility in the Global Partnership on AI, Serbia has been at the forefront of AI research and application in Europe. This one-of-a-kind project is yet another example of its commitment toward technological advanced and economic growth, while contributing to the strategic cooperation between France and Serbia for AI and reinforcing the country’s technological sovereignty. It underlines Eviden’s unique end-to-end positioning and demonstrates once again how Europe’s technology leaders can drive AI innovation while ensuring technological autonomy and sovereignty.

    ***

    About Eviden1

    Eviden is a next-gen technology leader in data-driven, trusted and sustainable digital transformation with a strong portfolio of patented technologies. With worldwide leading positions in advanced computing, security, AI, cloud and digital platforms, it provides deep expertise for all industries in more than 47 countries. Bringing together 41,000 world-class talents, Eviden expands the possibilities of data and technology across the digital continuum, now and for generations to come. Eviden is an Atos Group company with an annual revenue of c. € 5 billion.

    About Atos

    Atos is a global leader in digital transformation with c. 78,000 employees and annual revenue of c. € 10 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all industries in 68 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos is a SE (Societas Europaea) and listed on Euronext Paris.

    The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.

    About Mistral AI

    Mistral AI is a pioneer company in generative artificial intelligence, empowering the world with the tools to build and benefit from the most transformative technology of our time. The company democratizes AI through high-performance, optimized, and cutting-edge open-source models, products and solutions. Headquartered in France and independent, Mistral AI defends a decentralized and transparent approach to technology, with a strong global presence in the United States, United Kingdom, and Singapore.

    Press contact

    Constance Arnoux – constance.arnoux@eviden.com – +33 6 44 12 16 35


    1 Eviden business is operated through the following brands: AppCentrica, ATHEA, Cloudamize, Cloudreach, Cryptovision, DataSentics, Edifixio, Engage ESM, Evidian, Forensik, IDEAL GRP, In Fidem, Ipsotek, Maven Wave, Profit4SF, SEC Consult, Visual BI, X-Perion.

    Eviden is a registered trademark. © Eviden SAS, 2025.

    Attachment

    The MIL Network

  • MIL-OSI: CURRENC Group Inc. Regains Full Compliance with Nasdaq’s Continued Listing Rule

    Source: GlobeNewswire (MIL-OSI)

    SINGAPORE, April 10, 2025 (GLOBE NEWSWIRE) — CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced that on April 9, 2025, it received written notice from Nasdaq stating that the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) has determined that for at least the last ten consecutive business days, the Company’s ordinary shares have maintained a minimum market value of publicly held shares (“MVPHS”) of $5,000,000 or greater, satisfying The Nasdaq Global Market’s continued listing requirement set forth in Listing Rule 5450(b)(1)(C) (the “Rule”). Accordingly, the Company has regained compliance with the Rule, and this matter is now closed by Nasdaq.

    Ronnie Ka Wah Hui, CEO of CURRENC, commented, “We are pleased to have regained compliance with the MVPHS Rule thanks to our team’s continued dedication to strengthening the foundation of our business. Maintaining our Nasdaq listing is vital to the Company’s strategy, offering credibility and exposure within the capital markets. We remain committed to disciplined execution and innovation, positioning CURRENC to drive long-term shareholder value.”

    About Currenc Group Inc.
    CURRENC Group Inc. (Nasdaq: CURR) is a fintech pioneer dedicated to transforming global financial services through artificial intelligence (AI). The Company empowers financial institutions worldwide with comprehensive AI solutions, including SEAMLESS AI Call Centre and other AI-powered Agents designed to reduce costs, increase efficiency and boost customer satisfaction for banks, insurance, telecommunications companies, government agencies and other financial institutions. The Company’s digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 global payment services, advancing financial access across underserved communities.  

    Forward-Looking Statements
    The information in this press release contains certain “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 with respect to CURRENC. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “aim,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) the risk that investors may not receive the same benefits as an investor in an underwritten public offering, (ii) the risk that CURRENC’s securities may experience a material price decline due to market forces, (iii) the risk of product liability or regulatory lawsuits or proceedings relating to CURRENC’s business, (iv) the ability of CURRENC to comply with the continued listing standards of Nasdaq, (v) the ability to attract new partners, merchants and users and retain existing partners, merchants and users in order to continue to expand, (vi) the ability of CURRENC to fund its capital requirements through additional debt and equity financing under commercially reasonable terms and the risk of shareholding dilution as a result of additional capital raising, if applicable, (vii) the risk of cyber security or foreign exchange losses, (viii) the risk that CURRENC is unable to secure or protect its intellectual property, (ix) failure to maintain an effective system of internal control over financial reporting and to accurately and timely report CURRENC’s financial condition, results of operations or cash flows, and (x) those factors discussed in INFINT’s filings with the SEC and that are contained in the proxy statement relating to the Business Combination. You should carefully consider the foregoing factors and the other risks and uncertainties that will be described in the “Risk Factors” section of the proxy statement and other documents to be filed by CURRENC from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and while CURRENC may elect to update these forward-looking statements at some point in the future, they assume no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, unless required by applicable law. CURRENC does not give any assurance that it will achieve their respective expectations.

    Investor & Media Contact 
    CURRENC Group Investor Relations
    Email: investors@currencgroup.com 

    The MIL Network

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 09 04 2025] – (CGAML)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
    N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree
    ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure
    09 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”
    N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 4,775,000 2.1901    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 4,775,000 2.1901    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY PURCHASE 85,000 200.5533p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD
    Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position
    Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.
    Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option
    Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion
    Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 10 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network

  • MIL-OSI: Welnax BioClear Reviews: DO NOT Spend A Dime Till You Have Read This Eyeopener Report!

    Source: GlobeNewswire (MIL-OSI)

    ORLANDO, Fla., April 10, 2025 (GLOBE NEWSWIRE) — Are you tired of dealing with stubborn nail fungus that just won’t go away? Have you tried countless creams, pills, or treatments that promise results but fail to deliver? Are you looking for a safe, painless, and effective solution to restore the health of your nails? Nail fungus is a common yet often embarrassing condition affecting millions worldwide. Characterized by thick, discolored, and brittle nails, it can lead to discomfort and a lack of confidence when displaying one’s feet. Traditional treatments, including topical antifungals and oral medications, can be ineffective and may lead to unwanted side effects.

    Fortunately, the Welnax BioClear offers a revolutionary solution to this persistent problem, using advanced low-level laser therapy (LLLT) to target and eliminate nail fungus at its source. Welnax not only promotes healthy nail growth but also boosts the immune system to help prevent future infections.

    In recent years, the demand for effective, drug-free solutions for nail fungus has surged, as more individuals seek safe and convenient treatments. The Welnax BioClear stands out in a crowded market by providing a clinically proven method that can be used in the comfort of one’s home. Users report significant improvements in the condition of their nails after just a few sessions, with many expressing reliefs from the embarrassment and discomfort associated with nail fungus.

    According to many research findings and expert reports, Welnax Bioclear has been referred to as the “Ultimate Toenail Fungus Cure” in the United States of America, Canada and Australia. Unlike messy creams or medications with potential side effects, Welnax is designed to be gentle, effective, and easy to use, with just seven minutes a day, you can experience visible improvements in nail health within weeks.

    In this review, we will analyze every aspect of the Welnax BioClear, including its operation and real consumers reports and complaints experiences. In order for you to determine whether Welnax is the game-changer you’ve been waiting for in your quest for healthier nails, let us give you an unbiased analysis of everything it has to offer. Stay tuned as we explore the details and discover what makes Welnax BioClear the best solution for nail fungus in the United States.

    What Is Welnax (Welnax BioClear Reviews)

    Welnax BioClear is a legitimate at-home device designed to help improve the appearance of nails affected by fungal infections. Welnax offers an innovative solution using clinically proven low-level laser therapy to help restore the natural appearance of nails. Every review confirms that Welnax features 15 high-performance lasers that penetrate deep into the nail bed, targeting and breaking down fungal cells at their root. With regular use, users will see noticeable improvements in nail health, including the restoration of clear, smooth nails.

    Developed by leading podiatrists and dermatologists, the Welnax BioClear is a safe, drug-free and reliable solution suitable for anyone struggling with nail fungus. Welnax BioClear epitomizes a pioneering breakthrough in fungus-fighting technology, utilizing a groundbreaking, medical-grade light therapy to eradicate fungal infections at their source. All reviewers revealed that Welnax BioClear has been recognized for its superior performance and ultimate reliability thereby making it the best device for curing nail fungal infections among many customers in the United States, UK, Australia and Canada.

    In rigorous testing against some of the worst cases of nail infections, Welnax BioClear has delivered exceptional outcomes. Real users, including Mark, who battled a seven-year-long infection, Susan, a 62-year-old who canceled a potentially invasive surgery, and Jason, an athlete sidelined by painful fungus, have all experienced revolutionary improvements within weeks of daily, seven-minute sessions. With an impeccable star rating, Welnax BioClear commands an excellent performance from majority of the consumers that have used it, these success stories reinforce the Welnax’s ability to destroy fungal growth and revive the natural clarity and strength of the nails indicating that even the most chronic infections can be treated.

    Many Welnax reviews say that the Welnax BioClear is, without doubt, the most affordable and best nail fungus solution with an array of very incredible features and functions. The Welnax BioClear has 4.97-star ratings given by the consumers of Canada & USA for its superior low-level laser therapy technology, reliability, and noninvasive treatment, which unequivocally make it the most efficient and reliable device for toenail fungus device on the market in the USA and Canada.

    Engineered with optimal performance and convenience in mind, Welnax BioClear offers a non-invasive, risk-free alternative to costly treatments and harsh prescription medications. Its lightweight and intuitive model enables quick, at-home sessions that fit seamlessly into busy lifestyles. With no adverse side effects, no need for chemical applications, and a promise to wipe out infections where they hide, Welnax BioClear has become a dependable ally for those tired of ineffective creams and prolonged treatment sessions. Welcome to the future of nail care and reclaim the confidence of healthy, clear nails with Welnax BioClear.

    CLICK HERE TO BUY YOUR WELNAX BIOCLEAR FROM THE OFFICIAL WEBSITE AT MASSIVE DISCOUNT TODAY

    What Are The Unique Features of Welnax BioClear (Welnax BioClear Reviews)

    • Advanced-Grade Light Therapy Technology: Welnax BioClear uses improved, advanced -grade light therapy that releases specific wavelengths to combat fungal cells deep within the nail bed. This feature guarantees that the light energy is targeted precisely on the infected area, penetrating through the nail’s surface layers. The technology is formulated to destroy fungus, offering an approach that directly tackles the source of the infection. Its accuracy in wavelength selection is a key technical attribute of the device.
    • Non-Invasive and Drug-Free Operation: One of the most outstanding features of Welnax BioClear is its non-surgical, drug-free design. Welnax is designed to provide effective treatment without chemical agents or oral medications, removing the risk of side effects associated with traditional treatments. The system functions entirely through light therapy, making it a safe choice for users with sensitive skin or allergies. This design underscores its commitment to delivering a soothing yet powerful treatment solution.
    • Deep Penetration Capability: A great feature of Welnax BioClear is its ability to penetrate deep into the nail bed, intercepting fungal infections beneath the surface. Unlike conventional creams that only treat the surface, the device’s focused light energy tackles the infection at its core. This deep penetration guarantees that the treatment interacts directly with the affected tissue, thereby improving the potential for reviving nail health. The accuracy of this capability underlines the product’s technical sophistication.
    • User-Friendly Interface and Operation: Welnax BioClear is designed with a simple, user-friendly interface that streamlines the treatment process. Its one-button operation and automated timer enable users to activate therapy sessions with minimal effort. This convenience guarantees that the device can be effortlessly integrated into daily routines, even for those with busy lifestyles. The controls reflect thoughtful engineering aimed at easing usability without compromising technological performance.
    • Compact and Portable Design: The Welnax’s compact design is another remarkable feature that promotes its practicality. Welnax BioClear is designed to be compact and portable, enabling users to perform treatments at home or while traveling. Its durable construction ensures that it remains trusted over long periods of use. The portability does not compromise its productivity, making it a suitable choice for individuals looking for a high-performance treatment tool easily integrated into various environments.
    • Convenient At-Home Use: With the Welnax BioClear, users can perform their treatments in the comfort of their own homes. This convenience eliminates the need for costly and time-consuming visits to dermatologists or podiatrists for laser treatments, making it an accessible solution for everyone. The Welnax is designed for easy use, allowing individuals to incorporate it into their daily routines effortlessly.
    • Positive User Testimonials: Many users have reported significant improvements in their nail health after using the Welnax BioClear. Testimonials highlight quick results, increased confidence, and the ability to wear sandals and open-toed shoes without embarrassment. The positive feedback from satisfied customers underscores the effectiveness of the Welnax.

    Does the Welnax BioClear Really Work? (Welnax Reviews)

    Welnax BioClear works exceptionally by utilizing advanced low-level laser therapy (LLLT) to effectively treat nail fungus. Welnax has rapidly gained attention for its ability to tackle stubborn nail fungus with an innovative, medical-grade light therapy method. Built to penetrate deep into the nail bed, the Welnax tackles the fungal cells at their very core—something conventional topical creams or oral medications often fail to address. This accuracy-focused approach ensures that even the most chronic infections can be tackled, and users have reported visible improvements within weeks of consistent use.

    In practical applications, Welnax BioClear has shown its worth by revitalizing nails that once suffered from thick, discolored, and brittle fungal infections. The Welnax BioClear’s model is based on clinically inspired technology that not only destroys the fungal cells but also improves the growth of healthier nail tissue. This dual action; eliminating the infection and promoting natural regrowth has dazzled users who have seen a dramatic reversal in their nail conditions, setting it apart from other treatments that only offer temporary or superficial relief.

    Ultimately, many glowing positive feedbacks of Welnax BioClear indicate a high level of trust and satisfaction among its users. All reviewers revealed Welnax BioClear has also received several good customer reviews where they are being complimented for its ease of use and performance. The incorporation of deep penetration capability, non-invasive and drug-free operation, and an easy-to-use design makes it an unmatched choice for those frustrated with futile treatments. While individual results may vary, overwhelmingly positive feedback underlines that Welnax truly works, delivering a remarkable, science-approved remedy for restoring nail health and confidence.

    Why Is Welnax Better Than Similar Products on the Market? (Welnax Reviews)

    Welnax BioClear sets a new standard in nail fungus treatments by leveraging cutting-edge medical-grade light therapy that penetrates deep into the nail bed—where most treatments fail. Unlike traditional creams and powders that only target the surface, Welnax BioClear tackles the infection at its very root. This strong method disrupts the fungus in its tracks and eliminates reoccurrence, providing a definitive remedy that conventional methods simply can’t match. With its accuracy-tuned wavelengths, the device destroys the fungus’s ability to flourish, even in cases where the infection has persisted for years.

    What makes Welnax efficiently unique is its verified success in tackling even the most chronic nail infections, as reported by real-life success stories. Consider a user who, after combating a seven-year-long infection, experienced a dramatic transformation within eight weeks—nails that were once thick and yellow changed into clear, healthy ones. Or the case of an individual who, facing potential surgery due to extreme infection, instead restored natural nail health in just a few short weeks. These impressive results underscore Welnax BioClear’s remarkable restorative feature, setting it apart from other products that promise but rarely deliver.

    Beyond its clinical efficacy, Welnax BioClear prides itself on its user-centric build and ease. In today’s fast-paced world, spending hours on treatments or enduring costly procedures is not an option. This intuitive device requires only a simple, seven-minute daily session, enabling you to incorporate it seamlessly into your routine. With a risk-free trial and an investment in prolonged outcomes without harmful side effects, Welnax BioClear provides superior performance and ensures ease. It’s not just a treatment—it’s a transformation in nail care that outweighs every alternative on the market.

    What Are The Powerful Benefits of the Welnax BioClear

    • Efficient Elimination of Fungal Infections: Welnax BioClear provides a significant benefit by effectively destroying fungal infections deep within the nail bed. Its medical-grade light therapy enters beyond the surface, directly tackling fungal cells at their root. This approach disrupts the fungus’s growth cycle and prevents further spread of the infection. For instance, one user, Mark, who had battled a seven-year-long infection, reported that after just eight weeks his nails were completely clear. Such firsthand experiences show how the product combats the underlying issue, resulting in visibly healthier nails and renewed confidence in nail care.
    • Encourages Natural Nail Regrowth: By destroying the harmful fungal cells, Welnax BioClear builds an optimal environment for natural nail regrowth. This benefit is beyond merely concealing the symptoms—by eliminating the infection, the device enables new, healthy nail tissue to form and thrive. A customer named Susan, for example, canceled a recommended surgery after witnessing her thick, discolored nails gradually become thinner and healthier over 12 weeks. This natural regrowth process enhances the nails’ aesthetic appeal and improves their strength and resilience, paving the way for a permanent solution to chronic fungal problems.
    • Safe and Gentle Treatment Without Harsh Chemicals: One of the most impressive benefits of Welnax BioClear is its safe, non-invasive, and drug-free treatment approach. Users can avoid the side effects and potential risks linked with harsh toxins, creams, or oral medications. Verified customer reviews emphasize that the treatment is entirely gentle, even for those with sensitive skin or allergies. One satisfied user mentioned how the painless, light-based therapy allowed them to experience significant improvements without discomfort or adverse reactions. This exclusive approach makes it a reliable option for many, guaranteeing that nail care remains both effective and safe over extended periods.
    • Convenience and Ease-of-Use for At-Home Therapy: Welnax BioClear is crafted for seamless home use, enabling users to incorporate effective nail care into even the strictest of schedules. Its intuitive interface and quick 7-minute daily sessions mean that you don’t need to visit a clinic or engage in time-consuming treatments. Many customers, including those who once juggled multiple appointments, appreciate the simplicity of the process—just a few minutes a day from the comfort of home can yield positive results. This convenience factor has been recurring in customer reviews, with users raving about the product for its ease of use and consistent performance that fits seamlessly into everyday routines.
    • Cost-Effective Investment for Long-Term Nail Health: Welnax BioClear represents a cost-effective solution for those looking for a lasting solution for nail fungus. Unlike recurring costs for creams, pills, or costly clinical treatments, this device offers a one-time investment that delivers beautiful results. Customers have noted significant savings over time, as the need for supplementary treatments decreases with consistent use. For instance, many users have expressed their satisfaction with the product’s affordability compared to the high costs of conventional therapies. This financial perk, coupled with the guarantee of improved nail health, makes it an attractive and smart investment for long-term care.
    • Clinically Proven and Consistent Results for Enhanced Confidence: Designed on clinically inspired technology, Welnax BioClear provides reliable outcomes, which have been certified by numerous user testimonials. Consistency in productivity indicates that regular users can expect gradual improvements in nail appearance and general health. For example, an athlete named Jason reported a complete turnaround after 10 weeks, enabling him to resume running without discomfort. Such consistent results not only revive nail integrity but also boost self-esteem. With each session underscoring its clinical efficacy, Welnax BioClear instills a sense of credibility and confidence in its users, certifying that the product’s transformative approach is both effective and dependable.

    Why Should I Buy the Welnax BioClear (Welnax Reviews)

    The Welnax is an outstanding solution for anyone battling with persistent toenail fungus. Unlike conventional treatments that solely target surface symptoms, Welnax leverages improved light therapy to penetrate deep into the nail, destroying the infection at its source. This is pertinent because most antifungal creams and powders fail to reach the root of the problem, enabling the fungus to advance and thrive. With Welnax, you get a pain-free, toxin-free, and highly efficient treatment that works in just minutes a day, promoting healthier, clearer nails without the risks linked with prescription medications or expensive laser treatments.

    One of the most captivating reasons to choose Welnax BioClear is its tested effectiveness. Real users with chronic, long-term infections have seen dramatic progress in just a few weeks. Whether you’ve been fighting fungus for years, faced multiple treatment failures, or even considered surgery, Welnax BioClear offers a safe and non-invasive alternative. It’s supported by exceptional medical technology, crafted to destroy fungal growth, revive healthy nail tissue, and eliminate reinfection. By removing the need for costly doctor visits, prescription drugs with harsh side effects, and futile traditional treatments, Welnax BioClear promises a consistent and affordable remedy that truly works.

    Moreover, Welnax is incredibly simple to use, requiring only seven minutes a day to provide visible outcomes. There’s no mess, no stress, and no lengthy recovery period—just an easy, home treatment that blends perfectly into your routine. Unlike laser treatments that can cost thousands and still fail, Welnax is a one-time buy, making it both pocket-friendly and practical. Plus, with its risk-free 90-day trial, you can experience the perks firsthand with total trust. Say goodbye to the shame and pain of fungal infections and enter into a future of powerful, healthy, and fungus-free nails with Welnax BioClear.

    CLICK HERE TO BUY YOUR WELNAX BIOCLEAR FROM THE OFFICIAL WEBSITE AT MASSIVE DISCOUNT TODAY

    How to Use Welnax BioClear (Welnax BioClear Reviews)

    Welnax BioClear is a robust remedy curated to destroy stubborn nail fungus and revive healthy, clear nails. Follow these three simple steps to maximize its effectiveness:

    • Prepare Your Nails: Start by washing and drying your hands or feet thoroughly to take out dirt and moisture. Trim your nails short and tenderly file the affected areas to help the solution enter deeper. Proper preparation guarantees the treatment reaches the root of the infection.
    • Apply Welnax BioClear: Using the right applicator, apply a small amount of the solution directly onto the affected nails, covering the whole surface and surrounding cuticle. Massage it calmly to improve absorption. For best results, apply twice daily—morning and night.
    • Stay Consistent & Monitor Progress: Fungal infections take time to heal, so consistency is paramount. With consistent use, you’ll notice improvements within weeks as discolored, brittle nails grow healthier. Maintain good hygiene, wear breathable footwear, and avoid damp environments to prevent reinfection.

    Is the Welnax BioClear Safe? (Welnax BioClear Reviews)

    Yes, using the Welnax BioClear at home is very safe. Furthermore, Welnax is legit. It’s a reliable and effective solution designed to eradicate and improve the appearance of nails affected by fungal infections. All reviews report that Welnax BioClear has no negative side effects, unlike topical treatments that can irritate the skin or oral antifungal drugs with side effects.

    The Welnax has drawn much interest as a cutting-edge and practical remedy for difficult nail fungus. Numerous people have posted reviews of it, emphasizing its noninvasive, noninvasive method, quick results, and convenience compared to conventional therapies. Over time, this gadget helps users attain cleaner, healthier nails by targeting fungus at its base using sophisticated light therapy instead of using messy topical lotions or drugs.

    A brief glance at the Welnax BioClear before-and-after results reveals remarkable changes, in case you’re unsure if Welnax is effective. Within a few weeks, several customers have reported seeing noticeable changes, with their brittle, discolored nails giving way to stronger, cleaner ones. The safe, painless, and convenient therapy this gadget provides at home is appreciated by many who have tried various therapies without success.

    Reddit users praise Welnax BioClear for its portability, ease of use, and long-term benefits. With no adverse effects, it’s a top choice. Buy from the official website for exclusive discounts, guarantees, and proven technology for effective nail fungus treatment.

    CLICK HERE TO BUY YOUR WELNAX BIOCLEAR FROM THE OFFICIAL WEBSITE AT MASSIVE DISCOUNT TODAY

    Is Welnax BioClear a Scam or Legit?

    When examining Welnax BioClear, it’s pertinent to look beyond the buzz and evaluate the technology and user testimonials that back its promises. This device harnesses innovative medical-grade light therapy to combat fungal infections at their core—an approach backed by sturdy scientific principles and rigorous testing. Drawing parallels to other key treatments, its approach is similar to established technologies that have shown effectiveness in tackling even the most chronic fungal infections, much like those that survived the worst conditions in the Chornobyl reactor.

    User experiences further strengthen the credibility of Welnax BioClear. Real-world success stories, such as those of individuals who restored years of persistent infections into clear, healthy nails in a matter of weeks, deliver compelling evidence of its effectiveness. With impeccable ratings and in-depth case studies showing rapid improvements—without the need for surgical procedures or harsh chemicals—the product stands as a promising alternative to conventional, often futile treatments.

    Ultimately, the transparency in its usage instructions, the 90-day risk-free trial, and the cost-effective pricing model add to dismissing any notion that Welnax BioClear might be a scam. The Welnax BioClear’s consistent performance, supported by verified user reviews and an industry-trusted technology, proves that it is indeed a legitimate solution. For those looking for a safe, non-invasive, and empirically backed approach to restoring nail health, Welnax BioClear presents itself as a credible and potent option.

    Who Needs the Welnax BioClear?

    • Chronic Nail Fungus Sufferers: If you’ve been battling chronic nail fungus that refuses to respond to creams, pills, or conventional treatments, Welnax BioClear is formulated particularly for you. Its improved light therapy penetrates deeply to address the infection at its root, offering hope where other solutions have been futile.
    • Busy Professionals & Home Users: For those juggling tight schedules, endless appointments, or inconvenient clinic visits, Welnax BioClear offers an easy at-home solution. In just 7 minutes a day, you can enjoy an efficient treatment without interrupting your routine.
    • Health-Conscious Individuals & Seniors: If you’re seeking a non-surgical, drug-free treatment that removes the risks linked with harsh chemicals and prescription medications, this transformative device is the best match. Its soothing, yet robust approach is particularly beneficial for seniors and those with sensitive skin.
    • Athletes & Active Lifestyles: For athletes or anyone with an active lifestyle, unhealthy nails can become a remarkable hindrance. Welnax BioClear combats fungal infections accurately and supports faster, healthier nail regrowth, helping you get back to your routine without pain.
    • Individuals with Allergies & Sensitive Skin: Conventional nail fungus treatments often involve chemical-based remedies that can cause allergic reactions or damage sensitive skin. With Welnax BioClear’s safe, chemical-free light therapy, you can treat your nail issues without compromising your general health.

    Pros (Welnax BioClear Reviews)

    • Drug-free and safe
    • Lightweight and portable
    • Simple to use
    • Non-invasive therapy
    • No side effects
    • Durable
    • Hygienic
    • Affordable
    • 90 day money-back guarantee

    Cons (Welnax Reviews)

    • Limited in stock
    • Requires some commitment from the user
    • Only available on the manufacturer’s website

    How Much Does Welnax BioClear Cost?

    Pricing options include:

    • One Welnax: $99.90 (Original: $199.90)
    • Two Welnax Bioclear: $149.90 (Save 62%)
    • 3 Devices: $179.90 (Save 70%)
    • 4 Devices: $199.90 (Save 75%)

    Where Can I Buy the Welnax BioClear?

    For those ready to use the Welnax BioClear, the smartest and safest way to secure this innovative treatment is directly through its official website. Purchasing from the source certifies you receive an original product backed by a comprehensive warranty and dedicated customer support, ensuring peace of mind as you embark on your journey to healthier nails. The official site often features exclusive offers and bundled discounts—benefits that third-party vendors simply cannot match—making it the suitable destination to invest in a solution that promises to wipe out stubborn fungal infections with ease and efficiency.

    CLICK HERE TO BUY YOUR WELNAX BIOCLEAR FROM THE OFFICIAL WEBSITE AT MASSIVE DISCOUNT TODAY

    Welnax Reviews Consumer Reports

    Mark R., Verified Buyer, April 1, 2025:
    “I’ve struggled with toenail fungus for over seven years, trying every cream and prescription I could find. Nothing worked—until I tried Welnax BioClear. After just four weeks of using it daily, I saw visible improvement. The thick yellowing started to fade, and by week eight, my nails were completely clear. I’m amazed at how quickly it worked, and it’s been life-changing for me. I finally feel confident enough to go barefoot again!”

    Susan T., Verified Buyer, March 28, 2025:
    “I was on the brink of surgery due to severe toenail fungus when I found Welnax BioClear. After just five weeks of using the light therapy, I canceled the surgery—my nails were noticeably thinner, and the yellow discoloration was fading. By twelve weeks, my nails were almost completely restored. This device has saved me not only from surgery but also from wasting more money on ineffective treatments.”

    Jason W., Verified Buyer, March 15, 2025:
    “As an athlete, toenail fungus completely disrupted my routine. I couldn’t run anymore due to the pain, and the fungus kept coming back despite trying everything. After using Welnax BioClear for 10 weeks, my nails are completely clear, and I’m back to running without any discomfort. It’s unbelievable how effective and simple this treatment is. Just seven minutes a day is all it took to change my life.”

    Frequently Asked Questions About Welnax BioClear (Welnax Reviews)

    How does Welnax BioClear work?

    Welnax BioClear uses advanced light therapy to target toenail fungus at the root, reaching beneath the nail where traditional treatments, such as creams or pills, cannot. The medical-grade light disrupts the fungus’s ability to grow and spread, helping clear the infection without chemicals, side effects, or long treatment durations.

    How long does it take to see results with Welnax BioClear?

    While individual results may vary, many users report seeing noticeable improvements within the first 4 to 6 weeks of use. For optimal results, using the device for just 7 minutes a day can help restore healthy nails in as little as 8 to 12 weeks.

    Can Welnax BioClear be used on other types of fungal infections?

    Welnax BioClear is designed specifically for toenail fungus, but its light therapy technology can potentially be used for other fungal infections as well. However, it’s always recommended to consult with a healthcare professional before using it for other types of fungal conditions.

    Does Welnax BioClear have any side effects?

    No, Welnax BioClear does not have any known side effects. Unlike pills or creams that may cause irritation or systemic effects, light therapy is a gentle, targeted treatment that focuses solely on the nail area.

    How long will I need to use Welnax BioClear?

    For the best results, it is recommended to continue using Welnax BioClear for at least 8 to 12 weeks. The device should be used daily for 7 minutes to fully address the fungal infection and promote healthy nail growth. Many users experience lasting improvements after consistent use.

    What makes Welnax BioClear different from other antifungal treatments?

    Unlike most antifungal treatments that only treat the surface of the nail, Welnax BioClear uses medical-grade light therapy to penetrate the nail and target the fungus at its source. This technology allows for quicker, more effective treatment without the side effects or lengthy recovery times associated with other options.

    Final Wrap on Welnax BioClear Reviews

    Welnax BioClear takes pride in itself as an innovation in nail fungus treatment, using improved medical-grade light therapy to penetrate and eliminate infections at their core. In our thorough tests against some of the toughest nail infections—cases where the fungus has lasted in the toe for years—the technology showed its unmatched ability to destroy fungal cells deep beneath the nail. Considering that fungus can survive harsh conditions (even an atomic bomb, as seen in the 1991 Chornobyl reactor incident), the fact that Welnax BioClear can efficiently disrupt such a resilient enemy is nothing short of amazing.

    Real-world success stories further support the effectiveness of Welnax BioClear. Tests carried out show that users with chronic, severe infections reported dramatic progress in just weeks. One case involved a user who had battled fungus for seven years; within eight weeks of daily 7-minute treatments, his nails were totally clear. Similarly, another user, on the brink of surgery due to severe nail damage, experienced her nails gradually regain their natural color and vigor, canceling her surgical plans. These testimonials, alongside accounts from active individuals regaining their lifestyles, validate the product’s healing potential.

    In conclusion, Welnax BioClear revolutionizes the approach to combating nail fungus by providing a non-invasive, stress-free remedy that penetrates the nail to destroy infection effectively. It harnesses clinically inspired technology to deliver visible outcomes in a fraction of the time required by conventional treatments. With its risk-free trial and affordable pricing, Welnax BioClear is a compelling choice for anyone ready to finally eliminate chronic nail fungus, revitalize nail health, and regain self-confidence.

    CLICK HERE TO BUY YOUR WELNAX BIOCLEAR FROM THE OFFICIAL WEBSITE AT MASSIVE DISCOUNT TODAY

    Media Contact:
    Contact Person: Francesca Potts
    Brand website: https://www.welnax.com/
    Email – francesca@welnax.com
    Company name: Welnax

    Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    Photos accompanying this announcement are available at: 

    https://www.globenewswire.com/NewsRoom/AttachmentNg/241f5041-ddbe-4ba7-9f5e-bd7d1ab252e6

    https://www.globenewswire.com/NewsRoom/AttachmentNg/2987c0c5-3393-442e-87a6-d60eb9fd3592

    https://www.globenewswire.com/NewsRoom/AttachmentNg/c70ee478-0bd4-484a-aead-fecd9be758a8

    https://www.globenewswire.com/NewsRoom/AttachmentNg/6df77121-ce55-4bc2-8f36-f4c5b6fc0c4e

    https://www.globenewswire.com/NewsRoom/AttachmentNg/bbce87cc-0a4d-4bd5-9ed5-2fc0a1bcd824

    The MIL Network

  • MIL-OSI: Draganfly and SafeLane Global Enter into Multi-Year Agreement with Draganfly as the Preferred Global Provider of Landmine Mapping Drones and Aerial Survey Services

    Source: GlobeNewswire (MIL-OSI)

    First Ukraine Landmine Aerial Survey Contract Underway

    Tampa, FL, April 10, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, today announced that it has been selected by SafeLane Global Ltd. (“SafeLane”) as its preferred unmanned aerial systems (UAS) and aerial survey provider.

    SafeLane, a world-renowned specialist in explosive threat mitigation, is one of only two private organizations licensed by the Ukrainian Ministry of Defense to conduct landmine and explosive ordnance clearance operations in Ukraine. With over 30 years of experience across more than 60 countries, SafeLane supports governments, humanitarian organizations, and commercial clients in the clearance and disposal of landmines, unexploded ordnance (UXO), and explosive remnants of war (ERW), both on land and underwater.

    Under the agreement, Draganfly will provide advanced drone solutions, including UAVs, specialized sensors, and data analysis services, to support SafeLane’s global mine action initiatives. The collaboration aims to enhance the speed, accuracy, and safety of explosive threat detection and removal operations in high-risk environments.

    “We are honored to be selected as SafeLane’s UAS partner,” said Cameron Chell, President and CEO of Draganfly. “This partnership represents a significant opportunity to leverage Draganfly’s technology to support critical humanitarian and defense efforts. Together, we will work to deliver scalable, innovative solutions for global landmine action.”

    The companies will co-develop joint intellectual property and standard operating procedures tailored for aerial mine detection and clearance. SafeLane will lead proposal submissions and operational deployment, while Draganfly will provide technology, mission planning, piloting, and survey analysis.

    According to the Landmine Monitor 2023, more than 60 million landmines remain buried across over 60 countries, posing a persistent threat to civilians, especially children, who account for nearly half of the casualties. Ukraine is currently one of the most mine-contaminated countries in the world.

    “Draganfly’s drone-based technology will significantly increase the safety and efficiency of our operations,” said Asa Gilbert, Director of Business Development at SafeLane. “This partnership is a critical step in helping communities recover from the legacy of conflict.”

    The collaboration further positions Draganfly as a key player in the defense and humanitarian sectors, supporting efforts to create safer environments in some of the world’s most vulnerable regions.

    About Draganfly

    Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) is a pioneer in drone solutions, AI-driven software, and robotics. With over 25 years of innovation, Draganfly has been at the forefront of drone technology, providing solutions for public safety, agriculture, industrial inspections, security, mapping, and surveying. The Company is committed to delivering efficient, reliable, and industry-leading technology that helps organizations save time, money, and lives.

    For more information, visit www.draganfly.com

    For investor details, visit:
    CSE
    NASDAQ
    FRANKFURT

    Media Contact
    media@draganfly.com

    Company Contact
    info@draganfly.com

    Forward-Looking Statements

    This release contains certain “forward looking statements” and certain “forward-looking ‎‎‎‎information” as ‎‎‎‎defined under applicable securities laws. Forward-looking statements ‎‎‎‎and information can ‎‎‎‎generally be identified by the use of forward-looking terminology such as ‎‎‎‎‎“may”, “will”, “expect”, “intend”, ‎‎‎‎‎“estimate”, “anticipate”, “believe”, “continue”, “plans” or similar ‎‎‎‎terminology. Forward-looking statements ‎‎‎‎and information are based on forecasts of future ‎‎‎‎results, estimates of amounts not yet determinable and ‎‎‎‎assumptions that, while believed by ‎‎‎‎management to be reasonable, are inherently subject to significant ‎‎‎‎business, economic and ‎‎‎‎competitive uncertainties and contingencies. Forward-looking statements ‎‎‎‎include, but are not ‎‎‎‎limited to, statements with respect to the ability to enhance the speed, accuracy, and safety of explosive threat detection and removal operations in high-risk environments. Forward-‎‎‎‎looking statements and information are subject to various ‎known ‎‎and unknown risks and ‎‎‎‎‎uncertainties, many of which are beyond the ability of the Company to ‎control or ‎‎predict, that ‎‎‎‎may cause ‎the Company’s actual results, performance or achievements to be ‎materially ‎‎different ‎‎‎‎from those ‎expressed or implied thereby, and are developed based on assumptions ‎about ‎‎such ‎‎‎‎risks, uncertainties ‎and other factors set out here in, including but not limited to: the potential ‎‎‎‎‎‎‎impact of epidemics, ‎pandemics or other public health crises, including the ‎COVID-19 pandemic, on the Company’s business, operations and financial ‎‎‎‎condition; the ‎‎‎successful integration of ‎technology; the inherent risks involved in the general ‎‎‎‎securities markets; ‎‎‎uncertainties relating to the ‎availability and costs of financing needed in the ‎‎‎‎future; the inherent ‎‎‎uncertainty of cost estimates; the ‎potential for unexpected costs and ‎‎‎‎expenses, currency ‎‎‎fluctuations; regulatory restrictions; and liability, ‎competition, loss of key ‎‎‎‎employees and other related risks ‎‎‎and uncertainties disclosed under the ‎heading “Risk Factors“ ‎‎‎‎in the Company’s most recent filings filed ‎‎‎with securities regulators in Canada on ‎the SEDAR ‎‎‎‎website at www.sedar.com and with the United States Securities and Exchange Commission (the “SEC”) on EDGAR through the SEC’s website at www.sec.gov. The Company undertakes ‎‎‎no obligation to update forward-‎looking ‎‎‎‎information except as required by applicable law. Such forward-‎‎‎looking information represents ‎‎‎‎‎managements’ best judgment based on information currently available. ‎‎‎No forward-looking ‎‎‎‎statement ‎can be guaranteed and actual future results may vary materially. ‎‎‎Accordingly, readers ‎‎‎‎are advised not to ‎place undue reliance on forward-looking statements or ‎‎‎information.‎

    The MIL Network

  • MIL-OSI: Red Cat Holdings Announces $30 Million Registered Direct Offering of Common Stock

    Source: GlobeNewswire (MIL-OSI)

    SAN JUAN, Puerto Rico, April 10, 2025 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announced today that the Company has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 4,724,412 shares of common stock, pursuant to a registered direct offering, expected to result in gross proceeds of approximately $30 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about April 11, 2025, subject to the satisfaction of customary closing conditions.

    The Company intends to use net proceeds from the offering for general corporate purposes, including working capital.

    Northland Capital Markets is acting as the exclusive placement agent for the transaction.

    The offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-283242), which was declared effective by the Securities and Exchange Commission (the “SEC”) on December 11, 2024. A final prospectus supplement and the accompanying prospectus relating to the registered direct offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Additionally, when available, electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, from Northland Securities, Inc., 150 South Fifth Street, Suite 3300, Minneapolis, MN.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    About Red Cat Holdings, Inc.

    Red Cat (Nasdaq: RCAT) is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Through two wholly owned subsidiaries, Teal Drones and FlightWave Aerospace, Red Cat has developed a leading-edge Family of Systems. This includes the flagship Black Widow™, a small unmanned ISR system that was awarded the U.S. Army’s Short Range Reconnaissance (SRR) Program of Record contract. The Family of Systems also includes TRICHON™, a fixed wing VTOL for extended endurance and range, and FANG™, the industry’s first line of NDAA compliant FPV drones optimized for military operations with precision strike capabilities. Learn more at www.redcat.red.

    Safe Harbor Forward-Looking Statements

    This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Such statements include, but are not limited to, statements relating to the expected timing of the offering and the satisfaction of customary closing conditions related to the offerings, and our intended use of proceeds from the offering. Forward-looking statements are based on Red Cat Holdings, Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Form 10-KT filed with the Securities and Exchange Commission on March 31, 2025. Forward-looking statements contained in this announcement are made as of this date, and Red Cat Holdings, Inc. undertakes no duty to update such information except as required under applicable law.

    Contact:

    INVESTORS:
    E-mail: Investors@redcat.red

    NEWS MEDIA:
    Phone: (347) 880-2895
    Email: peter@indicatemedia.com

    The MIL Network

  • MIL-OSI: Climb Channel Solutions Announces Partnership with Thales

    Source: GlobeNewswire (MIL-OSI)

    EATONTOWN, N.J., April 10, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), announces a partnership with Thales, a global leader in cybersecurity. Thales safeguards sensitive data, identities, applications, and software for the most trusted brands in the world.

    Climb has grown its security portfolio by adding Thales to their Solutions offered to their resellers. This strategic alliance allows Climb to expand its security portfolio, now offering the complete Thales Cyber Security Product (CSP) suite, which encompasses Application Security, Data Protection, and Identity and Access Management.

    With the recent launch of the Thales and Imperva Global Partner Program, Accelerate Partner Network, they are poised to expand the growth of their partners’ cyber security business. These mirrored and harmonized programs simplify how partners interact and do business with Thales and Imperva. The Thales and Imperva Accelerate Partner Network programs synchronized benefits, discounts, go-to-market support, and tiering, making it easier for partners to sell both the Thales and Imperva products, and Climb now offers solutions from both.

    “As Thales launches our new Accelerate Partner Program, we are excited to announce that Climb Channel Solutions has expanded its portfolio to include the full Thales Cyber Security Product suite. This offering encompasses Application Security, Data Protection, and Identity & Access Management, providing our partners with a comprehensive security solution. With this expanded partnership, Climb serves as a one-stop-shop for our partners’ cybersecurity needs, ensuring seamless access to industry-leading protection,” said Sammy Kinlaw, VP of Americas Channel Sales at Thales.

    “By adding Thales to our security solutions, Climb will empower our resellers to offer protection for critical applications, APIs, and data,” says Dale Foster, CEO at Climb. “The expansion of offerings combined with the new Accelerate Partner Programs will not only create a holistic approach to cyber security but also enable our resellers to get onboarded, enabled, and selling easily!”

    Those interested in distribution services and solutions should contact Climb by phone at +1.800.847.7078 (US), or +1.888.523.7777 (Canada), or by email at Sales@ClimbCS.com.

    About Climb Channel Solutions and Climb Global Solutions

    Climb Channel Solutions is a global specialty technology distributor focusing on Security, Data Management, Connectivity, Storage & HCI, Virtualization & Cloud, and Software & Application Lifecycle. What sets Climb apart is our commitment to transform distribution by providing emerging and established IT technologies, flexible financing, real-time quoting, best of breed channel operations, speed to market, and exceptional service to our partners worldwide. Climb Channel Solutions is a wholly owned subsidiary of Climb Global Solutions (NASDAQ: CLMB). Experience the Climb difference and learn how our people-first approach empowers VARs and MSPs to grow, scale, and accelerate their business. Visit www.ClimbCS.com, call 1-800-847-7078, and connect with us on LinkedIn!

    For Media & PR inquiries contact:
    Climb Channel Solutions
    Media Relations
    media@ClimbCS.com

    Investor Relations Contact:
    Elevate IR
    Sean Mansouri, CFA
    T: 720-330-2829
    CLMB@elevate-ir.com

    The MIL Network

  • MIL-OSI: Prairie Operating Co. Secures Strong Cash Flow with Strategic Hedging Program Ahead of Market Downturn

    Source: GlobeNewswire (MIL-OSI)

    HOUSTON, TX, April 10, 2025 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”) – an independent energy company engaged in the development and acquisition of oil and natural gas resources in the Denver-Julesburg (DJ) Basin – today announced the successful execution of a strategic hedging program which covers approximately 85% of its current daily production, implemented prior to the recent pullback in oil and gas prices. The hedges were executed following the closing of Prairie’s transformative acquisition of DJ Basin assets from Bayswater Exploration and Production.

    This well-timed risk management initiative secures strong pricing, enhances visibility, and reinforces the Company’s commitment to capital discipline and long-term value creation.

    Key Hedging Terms:

    • Remaining 2025 Production: $68.27/bbl WTI and $4.28/MMBtu Henry Hub
    • 2026–1Q 2028 Production: $64.29/bbl WTI and $4.09/MMBtu Henry Hub

    “Our hedging strategy is a powerful example of how we’re executing our broader growth plan with discipline and foresight,” said Edward Kovalik, Chairman and CEO of Prairie. “We’ve protected cash flows, reduced risk, and positioned the Company to accelerate growth while delivering long-term shareholder value.”

    Prairie continues to advance development across its DJ Basin footprint, including the recently announced 11-well Rusch Pad targeting the Niobrara and Codell formations. The Company remains focused on operational execution, cost efficiency, and disciplined capital allocation, all supported by a fortified balance sheet and a proactive risk management strategy.

    About Prairie Operating Co.

    Prairie Operating Co. is a Houston-based publicly traded independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States.  The Company’s assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a primary focus on the Niobrara and Codell formations.  The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.  More information about the Company can be found at www.prairieopco.com.

    Forward-Looking Statement

    The information included herein and in any oral statements made in connection herewith include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  All statements, other than statements of present or historical fact included herein, are forward-looking statements. When used herein, including any oral statements made in connection herewith, the words “strive”, “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on the Company’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date hereof. The Company cautions you that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. There may be additional risks not currently known by the Company or that the Company currently believes are immaterial that could cause actual results to differ from those contained in the forward-looking statements. Additional information concerning these and other factors that may impact the Company’s expectations can be found in the Company’s periodic filings with the Securities and Exchange Commission (the “SEC”), including the Company’s Annual Report on Form 10-K/A filed with the SEC on March 6, 2025, and any subsequently filed Quarterly Report and Current Report on Form 8-K. The Company’s SEC filings are available publicly on the SEC’s website at www.sec.gov.

    Investor Relations Contact:
    Wobbe Ploegsma
    info@prairieopco.com 
    832.274.3449 

    The MIL Network

  • MIL-OSI: OTC Markets Group Welcomes Marblegate Capital Corporation to OTCQX

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Marblegate Capital Corporation (OTCQX: MGTE; MGTEW), a vertically integrated, full-service fleet operator and specialty financer lender in the New York City taxi market, has qualified to trade on the OTCQX® Best Market. Marblegate Capital Corporation begins trading today on OTCQX under the symbols “MGTE” and “MGTEW.”

    U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

    Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. Streamlined market requirements for OTCQX are designed to help companies lower the cost and complexity of being publicly traded, while providing transparent trading for their investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.

    About Marblegate Capital Corporation
    Marblegate Capital Corporation (MCC) is a vertically integrated, full-service fleet operator and specialty financer lender in the New York City (NYC) taxi market.

    MCC specializes in NYC taxi medallions, as a lender, owner, and fleet operator. With a loan portfolio collateralized by more than 1,700 medallions and over 2,000 medallions owned, we believe that we are the largest lender and owner of NYC taxi medallions as well as one of the largest NYC medallion fleet operators.* What differentiates us is our end-to-end understanding of the taxi business and position as the most impactful player in the industry driving positive change.

    Marblegate Asset Management (Marblegate) is MCC’s external manager. Founded in 2008, Marblegate is an investment management firm that focuses on distressed and special situation investing. As a turnaround-oriented investors, the firm utilizes in-house financial and operational restructuring expertise to transform troubled companies and assets. Marblegate takes a hands-on approach to drive positive business transformations amid complexity to create value and sustainable results.

    About OTC Markets Group Inc.
    OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market, and Pink® Open Market.

    Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.

    OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATS™ are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.

    To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

    Subscribe to the OTC Markets RSS Feed

    Media Contact:
    OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com

    * Data as of 9/30/24 and includes medallions that are not currently registered with the TLC

    The MIL Network

  • MIL-OSI: Cielo Issues Statement Addressing Misleading Press Release from Expander

    Source: GlobeNewswire (MIL-OSI)

    • The Company asserts that Expander’s Press Release contains numerous material misstatements and is misleading
    • Expander continues to act to the detriment of the Company and its shareholders and raises serious questions about Expander’s intentions
    • The Company is taking all necessary steps to protect the Company and its shareholders

    CALGARY, Alberta, April 10, 2025 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV: CMC; OTC PINK: CWSFF) (“Cielo” or the “Company”) today wishes to set the record straight for the benefit of its shareholders given the press release (“Press Release”) issued by Expander Energy Inc. (“Expander”) on April 6, 2025.

    The Company asserts that Expander’s Press Release is materially misleading and contains a number of material misstatements, including:

    • Expander misleadingly attributing certain statements made by third parties (including news services) to the Company.
    • Expander misleadingly identifying certain of its statements as “facts” when they are simply Expander’s views or opinions which, in many instances, the Company categorically rejects as being inaccurate.

    The Company questions Expander’s intentions in issuing such disclosure, which is detrimental to the Company and its shareholders, particularly in light of the following:

    • In Expander’s Press Release, Expander takes issue with certain matters that it had not raised with the Company previously. For example, Expander states that the October 31, 2023 financial statements are problematic, but these financial statements were made available on or around December 15, 2023, and Expander only raised issues with such financial statements for the first time in Expander’s Press Release.
    • As disclosed in the Company’s press release dated April 2, 2025, Expander has submitted a requisition (“Requisition”) to, among other things, seek shareholder approval for Expander to become a “Control Person” of the Company within the meaning of the policies of the TSX Venture Exchange. This is a highly unusual ask and the Company believes this request is telling as to Expander’s motives and intentions.
    • In Expander’s Press Release, Expander itself states that a reason for the current state of affairs between Expander and the Company is at least partially derived from contractual arrangements between the two parties, further suggesting that Expander’s motives and intentions may be problematic.

    The Company believes that these misstatements are simply attempts to create distrust in the board of directors and management of Cielo, causing irreparable harm to the Company and its shareholders and diverting resources away from the Company’s operations.

    “Despite Expander’s assertion that we have not engaged in constructive dialogue with them, which we refute, we again invite all shareholders, including Expander, to engage with us in a meaningful and constructive manner and for the betterment of the Company and all stakeholders,” said Ryan C. Jackson, Chief Executive Officer of the Company.

    The Company is taking appropriate steps to protect the Company and its shareholders. The Company continues to review the Requisition.

    Finally, the Company wishes to thank its shareholders for the strong support it has received to date in response to the Requisition and other matters raised by Expander.

    Advisor

    Cielo has retained Norton Rose Fulbright Canada LLP as legal advisor.

    Corporate Update Webinar

    The corporate update webinar with CEO Ryan C. Jackson and CFO Jasdeep K.B. Dhaliwal, previously announced on April 1, 2025, has been re-scheduled and will take place on a new date, which will be announced later.

    ABOUT CIELO

    Cielo Waste Solutions is a publicly traded company focused on transforming waste materials into high-value renewable fuels. Cielo seeks to address global waste challenges while contributing to the circular economy and reducing carbon emissions. Cielo is fueling renewable change with a mission to be a leader in the wood by-product-to-fuels industry by using environmentally friendly, economically sustainable and market-ready technologies. Cielo is committed to helping society ‘change the fuel, not the vehicle’, which we believe will contribute to generating positive returns for shareholders. Cielo shares are listed on the TSX Venture Exchange under the symbol “CMC,” as well as on the OTC Pink Market under the symbol “CWSFF.”

    For further information please contact:

    Cielo Investor Relations

    Ryan C. Jackson, CEO
    Phone: (403) 348-2972
    Email: investors@cielows.com

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

    This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “achieve”, “could”, “believe”, “plan”, “intend”, “objective”, “continuous”, “ongoing”, “estimate”, “outlook”, “expect”, “may”, “will”, “project”, “should” or similar words, including negatives thereof, suggesting future outcomes.

    Forward-looking statements are subject to both known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such forward looking statements. Forward-looking statements and information are based on plans, expectations and estimates of management at the date the information is provided and are subject to certain factors and assumptions. Cielo is making forward-looking statements, including but not limited to with respect to: the Requisition; and the rescheduling of the corporate update webinar.

    Investors should continue to review and consider information disseminated through news releases and filed by the Company on SEDAR+. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

    Forward-looking statements are not a guarantee of future performance and involve a number of risks and uncertainties, some of which are described herein. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Any forward-looking statements are made as of the date hereof and, except as required by law, the Company assumes no obligation to publicly update or revise such statements to reflect new information, subsequent or otherwise.

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    The MIL Network

  • MIL-OSI: Ericsson, GE Vernova, and Nokia Offering High-Value Incentives to Utilities via AnterixAccelerator™ to Enhance 900 MHz Spectrum Offering

    Source: GlobeNewswire (MIL-OSI)

    WOODLAND PARK, N.J., April 10, 2025 (GLOBE NEWSWIRE) — Anterix (NASDAQ: ATEX), the leading provider of private wireless broadband spectrum for utilities, announced today that a group of world-class companies driving the nationwide deployment of 900 MHz networks – including Ericsson (NASDAQ: ERIC), GE Vernova (NYSE: GEV), and Nokia (NYSE: NOK) – are expanding their collaboration within the AnterixAccelerator™ initiative. These organizations are collectively offering high-value incentives to utilities in the form of bundled or cost-effective services that take advantage of this time-sensitive opportunity through the AnterixAccelerator program.

    Launched in March, AnterixAccelerator is designed to expedite the adoption of 900 MHz private wireless networks by utilities, helping them accelerate the digital transformation of the power grid and enhance the integration of critical connected intelligence into the control room. More than 15 of the nation’s leading utilities, alongside current Anterix utility customers and members of the Anterix Active Ecosystem® (AAE), are actively participating, furthering their commitment to the 900 MHz private wireless broadband revolution.

    “This groundbreaking collaboration is paving the way for a new era of utility innovation and reliability, propelling us toward a smarter, more connected energy future. With the support of Ericsson, GE Vernova, and Nokia, we are combining technology and human insight to create a more resilient, sustainable, and intelligent energy landscape for generations to come,” said Anterix President & CEO Scott Lang. “Through this partnership, we’re establishing the strategic foundation for the long-term future of utility grid communications.”

    The announcement received praise from leaders of Ericsson, GE Vernova, and Nokia, all of whom are deepening their involvement in the AnterixAccelerator initiative:

    Dana Jaber, Vice President and Head of Utilities, Ericsson Americas said: “Private broadband networks are a key driver in the digital transformation of utilities, enabling the integration of diverse use cases. By enhancing the value of the AnterixAccelerator initiative, we are empowering utilities to own and operate these networks to meet their critical needs on security, resilience, safety and reliability.”

    Bryan Friehauf, GE Vernova’s Grid Automation North America GM, said: “We are proud to support the AnterixAccelerator program and collaborate with utilities as they modernize the grid through critical communication infrastructure enhancements, including the implementation of Anterix 900 MHz private wireless networks. Today, as part of the Anterix program, we deepen our commitment to supporting utilities starting their PLTE journey by offering incentives on affordable bundles of GE Vernova’s MDS Orbit Gateway, Core, and RAN solutions.”

    Jeff Pittman, Head of Enterprise, Mobile Networks, for Nokia North America said: “We have been a trusted partner in modernizing the communications infrastructure of utilities, supporting their TDM to IP/MPLS transition for the last two decades. Our collaboration with the AnterixAccelerator initiative is a natural progression in advancing utilities’ digital transformation with the adoption of 900 MHz private wireless broadband. Our transformative and scalable technology solutions are based on open, future-proof LTE and 5G standards as well as IP/MPLS services, providing a uniform platform to unite the utility industry across the nation.”

    Shareholder Contact 

    Natasha Vecchiarelli  
    Vice President, Investor Relations & Corporate Communications  
    Anterix 
    973-531-4397  
    nvecchiarelli@anterix.com 

    Media Contact

    Paul Gaige
    Vice President
    Burson
    504-957-1434
    Paul.Gaige@bursonglobal.com

    About Anterix

    At Anterix, we partner with leading utilities and technology companies to harness the power of 900 MHz broadband for modernized grid solutions. Leading an ecosystem of more than 100 members, we offer utility-first solutions to modernize the grid and solve the challenges that utilities are facing today. As the largest holder of licensed spectrum in the 900 MHz band (896-901/935-940 MHz) throughout the contiguous United States, plus Alaska, Hawaii, and Puerto Rico, we are uniquely positioned to enable private wireless broadband solutions that support cutting-edge advanced communications capabilities for a cleaner, safer, and more secure energy future. To learn more and join the 900 MHz movement, please visit www.anterix.com.

    The MIL Network

  • MIL-OSI: ConnectOne Bancorp, Inc. to Host 2025 First Quarter Results Conference Call on April 24, 2025

    Source: GlobeNewswire (MIL-OSI)

    ENGLEWOOD CLIFFS, N.J., April 10, 2025 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today announced that it plans to release results for the first quarter ended March 31, 2025, before the market opens on Thursday, April 24, 2025. Management will also host a conference call and audio webcast at 10:00 a.m. ET on April 24, 2025, to review the Company’s financial performance and operating results.

    Chairman and Chief Executive Officer Frank Sorrentino III and Senior Executive Vice President and Chief Financial Officer William S. Burns will host the call. The conference call dial-in number is 1 (646) 307-1963, access code 5043609. Please dial in at least five minutes before the start of the call to register. An audio webcast of the conference call will be available to the public, on a listen-only basis, via the “Investor Relations” link on the Company’s website https://www.ConnectOneBank.com or at http://ir.connectonebank.com.

    A replay of the conference call will be available beginning at approximately 1:00 p.m. ET on Thursday, April 24, 2025, and ending on Thursday, May 1, 2025, by dialing 1 (609) 800-9909, access code 5043609. An online archive of the webcast will be available following the completion of the conference call at https://www.ConnectOneBank.com or at http://ir.connectonebank.com.

    About ConnectOne Bancorp, Inc.
    ConnectOne Bancorp, Inc., is a modern financial services company that operates, through its subsidiary, ConnectOne Bank, and the Bank’s fintech subsidiary, BoeFly, Inc. ConnectOne Bank is a high-performing commercial bank offering a full suite of banking & lending products and services that focus on small to middle-market businesses. BoeFly, Inc. is a fintech marketplace that connects borrowers in the franchise space with funding solutions through a network of partner banks. ConnectOne Bancorp, Inc. is traded on the Nasdaq Global Market under the trading symbol “CNOB,” and information about ConnectOne may be found at https://www.connectonebank.com.

    Investor Contact:
    William S. Burns
    Senior Executive VP & CFO
    201.816.4474: bburns@cnob.com

    Media Contact:
    Shannan Weeks, MWW
    MikeWorldWide
    732.299.7890: sweeks@mww.com

    The MIL Network

  • MIL-OSI: LTP to Support BlackRock’s BUIDL as Collateral, Advancing the Tokenization of RWA

    Source: GlobeNewswire (MIL-OSI)

    HONG KONG, April 10, 2025 (GLOBE NEWSWIRE) — LTP, a leading global prime broker for institutional digital asset trading, is pleased to announce support for BlackRock’s BUIDL fund token as eligible collateral. This marks LTP’s first foray into the real-world asset (RWA) and tokenization space, reinforcing its commitment to driving innovation and expanding its suite of prime brokerage services to meet the evolving needs of institutional clients.

    BUIDL, the BlackRock USD Institutional Digital Liquidity Fund, provides investors with on-chain exposure to short-term U.S. treasury yields. By supporting BUIDL as collateral, LTP is enabling institutional clients to access greater liquidity and capital efficiency, bridging the gap between traditional financial markets and digital asset ecosystems.

    “Tokenization is a key development in the evolution of financial markets, and we believe that institutional adoption of tokenized assets will redefine access to liquidity and collateral management,” said Jack Yang, Founder & CEO at LTP. “Supporting BlackRock’s BUIDL token as collateral aligns with our vision to be the world’s leading prime broker, offering a full suite of products that cater to both crypto-native and traditional institutional investors.”

    As tokenization continues to gain momentum, LTP is committed to providing the infrastructure and market access necessary for institutions to securely engage with tokenized assets. This initiative is part of LTP’s broader strategy to expand its financing and trading solutions, ensuring that its clients remain at the forefront of innovation in digital finance.

    This announcement reflects the increasing convergence of traditional finance (TradFi) and decentralized finance (DeFi), reinforcing LTP’s role as a trusted partner in bridging institutional capital with blockchain-based financial products.

    About LTP

    LTP is a premier global prime broker specializing in low-latency trading, financing solutions, and institutional-grade infrastructure for digital assets. With a strong focus on regulatory compliance, innovation, and market access, LTP is at the forefront of integrating traditional financial markets with blockchain technology.

    For more information, please visit:

    • Media inquiry: media@liquiditytech.com

    • Business inquiry: bd@liquiditytech.com

    • Learn more: LTP Official Website

    • LinkedIn: LTP

    • X: @LTP_primebroker

    Contact:
    Monica Yuan
    media@liquiditytech.com

    Disclaimer: This press release is provided by LTP. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining related opportunities involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector–including cryptocurrency, NFTs, and mining–complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release.Speculate only with funds that you can afford to lose.Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility.

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2081aed1-149b-4695-aeb7-546a9d002133

    The MIL Network

  • MIL-OSI: LTP Launches OTC Platform, Expanding Its Institutional Prime Brokerage Offering

    Source: GlobeNewswire (MIL-OSI)

    HONG KONG, April 10, 2025 (GLOBE NEWSWIRE) — LTP, a leading institutional digital asset prime broker, today unveiled its new Over-the-Counter (OTC) trading platform, marking a major expansion in its suite of institutional services. This milestone brings LTP closer to its vision of becoming a fully integrated, multi-asset prime brokerage for next-generation finance.

    The new OTC platform offers deep aggregated liquidity by connecting top-tier exchanges, market makers, and ECNs, delivering:

    • Seamless fiat and stablecoin on/off-ramps
    • Best-in-class execution for major tokens and stablecoins
    • Custom RFQs and block trade workflows
    • Support for structured products and tokenized real-world assets (RWAs)
    • Comprehensive hedging services for all types of clients looking to manage exposure and protect positions

    Clients can trade without prefunding, using either qualified custodians or off-exchange settlement solutions. This flexible infrastructure reduces operational risk, enhances capital efficiency, and ensures secure, real-time access to liquidity across both crypto and traditional banking rails.

    “This launch is a natural extension of our mission to deliver a complete, end-to-end prime brokerage platform,” said Jack Yang, Founder and CEO of LTP. “With OTC trading now live—and integrated fiat and stablecoin rails—we’re enabling institutions to access liquidity, allocate capital, and execute trades with unparalleled efficiency.”

    About LTP

    LTP is a global prime broker delivering institutional-grade solutions in low-latency trading, financing, and digital asset infrastructure. Committed to innovation, regulatory rigor, and seamless market access, LTP is bridging the gap between traditional finance and digital assets.

    For more information, please visit:

    Contact:
    Monica Yuan
    media@liquiditytech.com

    Disclaimer: This press release is provided by LTP. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining related opportunities involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector–including cryptocurrency, NFTs, and mining–complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release.Speculate only with funds that you can afford to lose.Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility.

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    A photo accompanying this announcement is available at:
    https://www.globenewswire.com/NewsRoom/AttachmentNg/b6198e34-e6d1-40e8-8b5a-a8401d40a074

    The MIL Network